Effekte von Porphyromonas gingivalis Lipopolysacchariden auf humane Progenitorzellen aus dem dentalen Follikel in vitro by Chatzivasileiou, Kyriaki (gnd: 1064972225)
Aus der 
Poliklinik für Zahnerhaltung und Parodontologie am Universitätsklinikum Rostock 
Direktor: Prof. Dr. med. dent. Hermann Lang 
 
 
Effekte von Porphyromonas gingivalis Lipopolysacchariden 
auf humane Progenitorzellen aus dem dentalen Follikel in vitro 
 
 
 
Inauguraldissertation 
zur 
Erlangung des akademischen Grades 
Doktor der Zahnmedizin (Dr.med.dent.) 
der Universitätsmedizin Rostock 
 
 
 
vorgelegt von 
Kyriaki Chatzivasileiou 
geboren am 02.11.1982 in Xanthi, Griechenland 
 
 
Rostock, April 2014 
Dekan: Prof. Dr. med. habil. Emil Christian Reisinger 
From the 
Policlinic for Conservative Dentistry and Periodontology at Rostock University 
Director: Prof. Dr. med. dent. Hermann Lang 
 
 
Effects of Porphyromonas gingivalis Lipopolysaccharide 
on human dental follicle progenitor cells in vitro 
 
 
 
Dissertation 
to obtain the academic degree 
Doctor medicinae dentariae (Dr.med.dent.) 
at the Faculty of Medicine 
of Rostock University 
 
 
 
submitted by 
Kyriaki Chatzivasileiou 
born on 02.11.1982 in Xanthi, Greece 
 
 
Rostock, April 2014 
Dean: Prof. Dr. med. habil. Emil Christian Reisinger 
  
Die vorliegende Arbeit enstand in der Zeit von October 2009 bis September 2012 an der 
Klinik und Polikliniken für Zahn-, Mund- und Kieferheilkunde (ZMK), an den 
Forschungslaboratorien für kardialen Gewebe- und Organersatz (FKGO) sowie am 
Referenz- und Translationszentrum für kardiale Stammzelltherapie (RTC) der Klinik 
und Poliklinik für Herzchirurgie des Universitätsklinikums Rostock. 
 
 
 
 
 
 
Dekan:    Prof. Dr. med. habil. Emil Christian Reisinger 
1. Gutachter: Prof. Dr. med. dent. Hermann Lang 
2. Gutachter: Prof. Dr. med. Gustav Steinhoff 
3. Gutachter: Prof. Dr. med. dent. Michelle Alicia Ommerborn 
 
 
 
 
Parts of this dissertation have been published: 
 
Original research article: 
Chatzivasileiou K, Lux CA, Steinhoff G, Lang H. Dental follicle progenitor cells 
responses to Porphyromonas gingivalis LPS. J Cell Mol Med 2013; 17(6):766-73.     
doi: 10.1111/jcmm.12058. Impact Factor (2012): 4.753. 
 
Poster and oral presentations: 
Chatzivasileiou K, Lux CA, Steinhoff G, Lang H. Dental follicle progenitor cells 
responses to P.gingivalis LPS. Poster presented at the Pan European Regional meeting 
of the International Association for Dental Research (PER - IADR), September 12 - 15, 
2012, Helsinki, Finland. 
Chatzivasileiou K, Lux CA, Lang H, Steinhoff G. Effects of Porphyromonas 
gingivalis Lipopolysacharide on dental follicle progenitor cells. Poster presented at the 
meeting of the Continental European Division of the International Association for 
Dental Research (CED - IADR), August 31 - September 3, 2011, Budapest, Hungary. 
Chatzivasileiou K. Dental Follicle Progenitor Cells. The promise of periodontal 
regeneration. Lecture given at the bone regeneration research group colloquium of 
Rostock University, January 17th, 2013, Rostock, Germany. 
 
 
Research grant: 
This study was financially supported by the FORUN research grant awarded by the 
Medical School at Rostock University (Nr. 889011). 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Στον Όδυσσέα 
 
 
 
Contents    iv 
Contents 
      Contents          iv 
      List of abbreviations         vi 
      List of table and figure legends        viii 
1.   Introduction         1 
1.1   Periodontal regeneration        1 
1.1.1   Tooth morphogenesis       1 
1.1.2   Anatomy of the periodontal ligament     3 
1.1.3   Periodontal disease       4 
1.1.4   Periodontal therapy       6 
1.1.5   Rationale for regenerative periodontal therapy    8 
1.2   Human dental follicle progenitor cells      9 
1.2.1   Stem cells of non-dental origin      9 
1.2.2   Dental-derived progenitor cells      11 
1.2.3   Dental follicle progenitor cells      13 
1.3   Porphyromonas gingivalis       14 
1.3.1   General characteristics       14 
1.3.2   Association with periodontal disease      15 
1.3.3   P. gingivalis LPS        17 
1.3.4   Target cell receptors of P. gingivalis LPS     18 
1.4   Hypothesis statement        19 
2.   Materials and methods        21 
2.1   Cell isolation and culture        21 
2.1.1   Isolation and culture of human DFPCs and BMSCs    21 
2.1.2   Cell culture of human DFPCs and BMSCs     23 
2.1.3   Cryopreservation of cells       25 
2.2   In vitro cell characterization       26 
2.2.1   Colony forming assay       26 
2.2.2   MTT dye reduction assay       27 
2.2.3   In vitro functional differentiation assay     27 
2.2.4   Cell staining for immunofluorescence microscopy    30 
2.2.5   Fluorescence-activated cell sorter analysis     31 
Contents    v 
2.3   LPS treatment         33 
2.3.1   LPS treatment and cytotoxicity assay      33 
2.3.2   RNA extraction and complementary DNA synthesis    34 
2.3.3   Quantitative real-time PCR       35 
2.3.4   TLR expression by FACS       35 
2.3.5   In vitro wound healing assay      36 
2.3.6   Detection of IL-6 by ELISA      37 
2.4   Statistical analysis        38 
3.   Results          39 
3.1   Cell characterization        39 
3.1.1   Isolation and culture of DFPCs      39 
3.1.2   Clonogenic and proliferative properties of DFPCs    39 
3.1.3   Immunophenotypic characterization of DFPCs    41 
3.1.4   Differentiation potential of DFPCs      42 
3.2   LPS treatment         43 
3.2.1   LPS cytotoxic effects on DFPCs      43 
3.2.2   TLR2 and TLR4 expression in DFPCs     43 
3.2.3   Migration potential of DFPCs      45 
3.2.4   IL-6 secretion by DFPCs       46 
4.   Discussion          47 
4.1   Cell characterization        47 
4.2   Effects of P.gingivalis LPS on DFPCs in vitro     48 
4.2.1   Effects on cell viability       48 
4.2.2   Effects on TLR2 and TLR4 expression     49 
4.2.3   Effects on cell migration potential      50 
4.2.4   Effects on IL-6 secretion       51 
5.   Conclusions          52 
6.   Summary          53 
7.   Thesis statements         55 
8.   References          56 
9.   Acknowledgements         70 
10. Appendix          71 
List of abbreviations    vi 
List of abbreviations 
 
APC   allophycocyanin 
αMEM   alpha minimum essential medium 
bFGF   basic fibroblast growth factor 
BMSC   bone marrow stem cell 
BSA   bovine serum albumin 
CD   cluster of differentiation 
CDD   comment-driven development 
CPS   capsular polysaccharide 
DAPI   4', 6-diamidino-2-phenylindole 
dATP   deoxyadenosine triphosphate 
dCTP   deoxycytidine triphosphate 
DFPC   dental follicle progenitor cell 
dGTP   deoxyguanosine triphosphate 
DMEM    Dulbecco’s modified Eagle’s medium 
DMSO   dimethylsulfoxide 
DNA   deoxyribonucleic acid 
dNTP   desoxynucleoside triphosphate 
dT   deoxythymidine 
dTTP   deoxythymidine triphosphate 
EDTA   ethylenediaminetetraacetic acid 
ELISA   enzyme linked immunosorbent assay 
EMD   enamel matrix derivative 
ERK   extracellular-signal-regulated kinase 
ESC    embryonic stem cell 
FGF   fibroblast growth factor 
GAPDH   glyceraldehyde 3-phosphate dehydrogenase 
HSA   human serum albumin 
IL   interleukin 
iPSC   induced pluripotent stem cell 
LPS   lipopolysaccharide 
List of abbreviations    vii 
MAPK   mitogen-activated protein kinase 
mRNA   messenger ribonucleic acid 
MSC   mesenchymal stem cell 
MSCGM  mesenchymal stem cell growth medium 
MTT   3- (4, 5- dimethylthiazol-2-yl)-2, 5- diphenyltetrazolium bromide 
NF-κB   nuclear factor kappa-light-chain-enhancer of activated B cells 
OS   oligosaccharide 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
PDL   periodontal ligament 
PDLSC   periodontal ligament stem cell 
PE   phycoerythrin 
PerCP-Cy5.5  peridinin chlorophyll protein-cyanine 5.5 
PFA   paraformaldehyde 
PI3K   phosphatidylinositide 3-kinase 
PMN   polymorphonuclear leukocyte 
RNA   ribonucleic acid 
SE   standard error 
SRP   scaling and root planing 
STAP   stimulus-triggered acquisition of pluripotency 
TDM   treated dentin matrix 
TGF-β   transforming growth factor beta 
TLR   toll-like receptor 
TMB   3, 3’, 5, 5’- tetramethylbenzidine 
TNF-α   tumor necrosis factor alpha 
USA   United States of Amerika 
VEGF   vascular endothelial growth factor 
WHO   world health organization 
 
List of table and figure legends    viii 
List of table and figure legends 
 
List of table legends 
Table 2.1.1 Patient inclusion and exclusion criteria. 
Table 2.2.4 Antibodies for immunofluorescence microscopy. 
Table 2.2.5 Antibodies for analytical fluorescence-activated cell sorting. 
Table 2.3.4 Antibodies for analytical fluorescence-activated cell sorting. 
 
List of figure legends 
Figure 1.1.1 Schematic illustration showing different stages of human tooth formation. 
Figure 1.1.2 Schematic illustration showing structures of the periodontium. 
Figure 1.1.3 Radiographs featuring (A) healthy and (B) diseased periodontal tissues. Arrows 
indicate margins of the alveolar bone. 
Figure 1.1.4 Schematic illustration of guided tissue regeneration technique. 
Figure 1.2.1 Graphic illustration of the two main characteristics of stem cells. 
Figure 1.2.3 Panoramic radiograph of a 17 years old patient showing wisdom tooth follicle. 
Figure 1.4 Experimental design of the study. 
Figure 2.1.1 Schematic overview of DFPCs isolation procedure. 
Figure 2.2 Overview of in vitro cell characterization. 
Figure 2.3 Overview of in vitro cell characterization after LPS treatment. 
Figure 3.1.1 Microscope images showing typical (A) DFPCs and (B) BMSCs morphology, 100x. 
Figure 3.1.2a Representative light microscope images of a DFPCs colony after (A) 1 day, (B) 4 days 
and (C) 7 days of cultivation, 100x magnification. (D) Colony forming efficiency of 
DFPCs and BMSCs; DFPCs n = 5, BMSCs n = 4, values represent means ± SE,         
*p < 0.05 (Student’s t-test). 
Figure 3.1.2b Cell proliferation rates of DFPCs and BMSCs assessed by MTT dye reduction assay; 
DFPCs n = 5, BMSCs n = 4, values represent means ± SE. 
List of table and figure legends    ix 
Figure 3.1.3 (A) Immunophenotyping of human DFPCs by flow cytometry after staining for specific 
CD surface markers. DFPCs were positive for typical stem cell markers CD29, CD44, 
CD73, CD90 and CD105. No expression of haematopoietic markers CD14 and CD45 
was detected. Bright areas indicate CD marker isotope controls. (B) Surface marker 
expression values are presented in percentages; n = 3, values represent means ± SE. 
Figure 3.1.4 Multiple mesodermal lineage differentiation capacity of DFPCs in vitro. Adipogenesis 
was confirmed by Oil Red O staining (a) and immunostaining (d), 400x. Osteogenesis 
became evident after Alizarin Red staining (b) and immunostaining (e), 100x. Chondro-
genesis was verified by Safranin O staining (c) and immunostaining (f), 10x; n = 3. 
Figure 3.2.1 Cell viability rates of DFPCs and BMSCs assessed by MTT dye reduction assay; 
DFPCs n = 7, BMSCs n = 6. 
Figure 3.2.2a (A) Relative gene expression of TLR2 and TLR4 analysed by qRT-PCR. Histogram 
scale is inverted, so that higher bars represent higher levels of mRNA; DFPCs n = 4, 
BMSCs n = 3, values represent means ± SE, *p < 0.05 (Student’s t-test). (B) Gene 
expression fold change of TLR2 and TLR4 after LPS treatment. Data were analyzed by 
the delta/delta calculation method; DFPCs n = 4, BMSCs n = 3, values represent means 
± SE, *p < 0.05, **p < 0.01 (Student’s t-test). 
Figure 3.2.2b (A) Protein expression of TLR2 and TLR4 in DFPCs and BMSCs was evaluated by 
flow cytometry. Representative FACS histograms of TLR2 and TLR4 expression are 
shown. (B) TLR2 and TLR4 were expressed at low levels on both DFPCs and BMSCs. 
The expression of TLR2 was significantly lower than TLR4. The TLRs expression 
level of DFPCs was not significantly influenced by LPS treatment, while the expression 
of TLR4 on LPS-treated BMSCs was elevated; DFPCs n = 5, BMSCs n = 4, values 
represent the means ± SE, *p < 0.05, **p = 0.01, ***p < 0.001 (Student’s t-test). 
 
Figure 3.2.3 (A) Representative images of in vitro wound healing scratch assay. After scratching a 
confluent cell monolayer of cells, surrounding cells migrated into the scratched area 
(time after scratching is indicated). White lines represent wound edges at t = 0 hour. 
Dotted red lines represent wound dimensions during cell migration at three different 
time points, 10x. (B) Migratory activity rates after LPS treatment. Average wound 
dimensions were measured at several time points; data were normalized to untreated 
controls and results were expressed as percentages of migratory activity; DFPCs n = 4, 
BMSCs n = 3, values represent means ± SE, *p < 0.05 (Student’s t-test). 
 
Figure 3.2.4 Histograms show IL-6 secretion by DFPCs and BMSCs, measured after 24 hours (A) 
and 72 hours (B) of LPS stimulation by ELISA. Limit of detection was 8 pg/ mL. Each 
sample was tested in triplicate; DFPCs n = 3, BMSCs n = 5, values represent means ± 
SE, p > 0.05 (Student’s t-test). 
Intoduction    1 
 
1. Introduction 
1.1 Periodontal regeneration 
1.1.1 Tooth Morphogenesis  
In the past decades, a wealth of information has become available shedding light on the 
processes of teeth evolution. It is now widely accepted that odontogenesis begins in the 
sixth week of embryonic development with the formation of the primary dental laminae 
(odontogenic bands). These odontogenic bands are thickened U-shaped epithelial ridges 
along the processes of the developing jaws (Smith 2003). Teeth morphogenesis is 
regulated by sequential and reciprocal inductive interactions between the oral 
epithelium and the underlying neural crest-derived mesenchymal cells 
(ectomesenchyme) of the developing first branchial arch (Martens 2013). These 
interactions result in teeth formation (Fig. 1.1.1) through a series of different stages 
(lamina stage, bud stage, cap stage, and bell stage), mediated by numerous growth 
factors including members of the fibroblast growth factor (FGF) and transforming 
growth factor beta (TGF-β) superfamilies (Kettunen 2000; Nadiri 2004). It has recently 
become evident that more than 300 genes, mainly involved in regulation of cellular 
communication, may be associated with odontogenesis and the differentiation of dental 
tissues (Thesleff 2006). 
 
 
Figure 1.1.1 Schematic illustration showing different stages of human tooth formation  
  (Tucker 2004). 
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The oral epithelium is speculated to produce the first inductive signals to initiate 
odontogenesis (Modino 2005). However, the crucial role of cranial neural crest-derived 
cells in teeth evolution has been demonstrated in animal models, where transplantation 
of mice neural crest cells into chicken embryos allowed growth of tooth germs in vivo 
(Mitsiadis 2003). Hence, the contributions of each tissue, oral epithelium and 
ectomesenchyme, remain enigmatic and have been the basis of numerous debates 
(Hammarström 1996; Ten Cate 1996). 
The classical theory suggests that interactions and signals exchanged between epithelial 
and mesenchymal cells result in the segregation of dental epithelium into an outer layer 
of enamel (enamel organ) formed by ameloblasts, while dental papilla and follicle are 
supposed to be ectomesenchymal derivates. Particularly, dental papilla, located in the 
central chamber of the developing tooth bud, gives rise to dentin-forming odontoblasts 
and the dental pulp. 
Dental follicle is described as a loose ectomesenchymally-derived connective tissue sac 
surrounding the enamel organ and dental papilla of the tooth germ (Schroeder 1986; 
Moxham 1995; Ten Cate 1997). Anatomically, dental follicle consists of three layers: 
the dental follicle proper (associated with the tooth), the perifollicular mesenchyme 
(associated with the bone) and an intermediate layer of loose connective tissue. Dental 
follicle plays a central role in tooth eruption, as demonstrated by animal studies 
showing that removal of dental follicle from teeth prevented their eruption (Cahill 
1980). The developmental potential of dental follicle was extensively studied in 
numerous tooth transplantation experiments (Hoffman 1966; Ten Cate 1970; Palmer 
1987). It has been demonstrated that dental follicle harbours progenitor cells able to 
give rise to all components of the periodontium, including cementoblasts, periodontal 
ligament fibroblasts and osteoblasts (Diekwisch 2001; Morsczeck 2005; Yao 2008; 
Dieu 2009). However, the precise role of dental follicle in the differentiation and 
maturation of these tissues remains unclear because of the proximity to other embryonic 
tissues, as the Hertwig’s epithelial root sheath (Hoffman 1960; MacNeil 1993). 
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1.1.2 Anatomy of the periodontal ligament 
The periodontium is a complex organ consisting of epithelial, connective and 
mineralized tissues that invest and support the tooth (Pitaru 1994). The structures 
comprising the periodontium include cementum, periodontal ligament (PDL), alveolar 
bone and the gingival (Fig. 1.1.2). Structural integrity and interaction between these 
tissues are required for the proper function of the periodontium (Nanci 2013). Its 
primary role is the attachment of teeth to the alveolar bone and distribution of forces to 
surrounding bone by tooth loads. The periodontium serves also as a sensory organ, 
important for the positioning of the jaws during mastication and occlusion (Trulsson 
2006).  
 
Figure 1.1.2 Schematic illustration showing structures of the periodontium (Bird 2002). 
The integral part of the periodontium is the periodontal ligament, a soft, specialized 
connective tissue situated between the cementum and the alveolar bone. Periodontal 
ligament is adapted to the adjacent tissues by so-called principal fibers. These are 
collagenous fibers mainly consisting of collagen type I, III and XII being arranged in 
definite and distinct bundles and anchored in cementum or bone (Sharpey’s fibers). The 
average width of PDL ranges from 0.21 mm at 11 to 16 years of age to 0.15 mm at 51 
to 67 years, and has a hourglass shape with the narrowest area at the mid root level 
(Nanci 2013). The width of the ligament is dependent on vascularity, cell mitotic 
activity and fiber number and can adapt to forces in cases of decreased occlusal load or 
hyperfunction (Van der Velden 2004). 
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The periodontal ligament contains a unique assortment of cells including osteoblasts, 
cementoblasts, osteoclasts, multipotent stem cells, epithelial cell rests of Malassez, 
macrophages and fibroblasts, which are the most abundant cell population (Carranza 
2003). Periodontal ligament fibrobasts are responsible for the synthesis of collagen and 
its assembly into collagen fibers and contribute to the continuous remodeling taking 
place in the ligament. Particularly, periodontal ligament fibrobasts are considered to be 
mechanoresponsive and transmit mechanical forces to the supporting alveolar bone 
(Wescott 2007). This load transduction is thought to initiate a process associated with 
changes in bone architecture needed for tooth movement and adaptation to changing 
mechanical loads (Diercke 2011). This process is termed bone remodeling and is 
characterized by continuous bone resorption and new bone formation that is mainly 
controlled by osteoblasts (Sandy 1993). Moreover, the periodontal ligament includes 
neurovascular structures that are responsible for the sensory and nutritive function of 
PDL. Concretely, PDL includes endothelial cells, which line the numerous blood 
vessels that provide nutrients to cementum and alveolar bone. The periodontal nerve 
branches contain a mixture of myelinated and non-myelinated axons (Nakamura 1986) 
transmitting mechanical stimuli able to evoke various oral reflexes (Shi 2005). Finally, 
it is widely accepted that periodontal ligament cells play a crucial role in homeostasis, 
healing and regeneration of the periodontium (Shimono 2003; Scanlon 2011; Yu 2013). 
This potential has been in focus of periodontal research over the past few decades 
(Melcher 1976; Nyman 1982).  
 
1.1.3 Periodontal disease  
Periodontal disease is a bacterially induced inflammatory disease of the periodontium. 
It is characterized by the progressive destruction of periodontal tissues that eventually 
leads to the loosening and subsequent loss of teeth (Fig. 1.1.3). It represents one of the 
major dental diseases that affect human populations worldwide at high prevalence rates. 
Specifically, it is estimated that over 47% of the adult USA population is affected from 
periodontitis (Burt 2005), while 28.5% of tooth extractions in Germany are attributed to 
the disease (Glockmann 2011). Consequently, periodontal disease can significantly 
affect patients’ quality of life and lead to both financial and health related risks 
(Petersen 2005). Recent cross-sectional epidemiological studies have demonstrated that 
Intoduction    5 
 
at global level improvement of periodontal health can be possible over time (Hugoson 
2008). Nevertheless, according to a report of the World Health Organization (WHO), 
10 - 15% of world populations still suffer from severe periodontitis, an advanced form 
of the disease (Petersen 2005). Alarming is, also, the fact that diverse forms of 
periodontal diseases affect children, adolescents and young adult populations around 
the world (Albandar 2002).  
 
     
Figure 1.1.3 Radiographs featuring (A) healthy and (B) diseased periodontal tissues. Arrows 
indicate margins of the alveolar bone. 
 
Periodontal disease was first described by Gottlieb as a degenerative disorder leading to 
a diffuse atrophy of the alveolar bone (Gottlieb 1928). Until the early 80s, the term 
periodontosis, coined by Orban and Weinman, was used to denote the non-
inflammatory status of the disease (Orban 1942). Advances in dental research have 
fundamentally changed our understanding of the periodontal diseases (Baer 1971). It 
has been demonstrated that periodontitis is an inflammatory disease mainly caused by 
the presence of oral microbial biofilms. Since the first characterization of dental biofilm 
by van Leeuwenhoek in 1683 a great effort has been made to identify the microbiota at 
sites of periodontal lesions (Dobell 1958) and to determine the composition of perio-
pathogenic biofilms (Holt 2005). A microbial-shift from mostly Gram-positive to 
mostly Gram-negative species is supposed to lead the transition process from 
periodontal health to periodontal disease (Darveau 2010). Moreover, it has been 
speculated that specific bacteria or their consortia may be responsible for the initiation 
and progression of periodontal disease. Specifically, the ‘red complex’, consisting of 
Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia, has been 
proposed as a ‘disease-related’ network of pathogenic bacteria, being strongly related to 
chronic periodontitis (Socransky 1998). Nevertheless, the impact of polymicrobial 
communities on the development and progression of the disease remains unclear. 
A. B. 
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Over the last few decades, the key role of immune host response has been in focus of 
studies on the expression of periodontitis (Darveau 1997). Results of clinical studies 
challenged the idea that direct effects of bacterial toxins or enzymes were sufficient for 
the induction of periodontitis (Hirschfeld 1978; McFall 1982). These observations were 
further confirmed by longitudinal epidemiologic analyses on patients susceptibility to 
periodontal infections (Hugoson 1982; Lindhe 1983). While the etiology of 
periodontitis is bacterial, it has become evident that an inadequate host inflammatory-
immune response to periodontal pathogens is responsible for the disruption of tissue 
homeostasis in the pathogenesis of the disease (Van Dyke 2008; Darveau 2010). 
According to current literature, the destruction of periodontal tissues is neutrophil-
mediated and may lead to chronic inflammatory processes (Van Dyke 2003). Thus, 
genetic polymorphisms in cytokine expression or polymorphonuclear leukocytes 
(PMNs) dysfunctions have been associated with periodontitis (Kornman 1998; Kinane 
2001). Further, periodontal diseases were linked with major systemic diseases such as 
cardiovascular diseases, rheumatoid arthritis and diabetes (Beck 2000; Garcia 2001; 
Mealey 2006; Preshaw 2013). Such associations may reflect the presence of common 
underlying pathogenic mechanisms between periodontitis and general health and 
remain to be clarified (Armitage 2009). 
 
1.1.4 Periodontal therapy 
The ultimate goal of periodontal treatment is the restoration of homeostasis between 
periodontium and oral microbiota, the long-term maintenance of clinical periodontal 
attachment levels and the regeneration of lost periodontal supporting tissues (Van Dyke 
2008). The conventional periodontal treatment involves the mechanical removal of the 
pathogenic dental biofilm by scaling and root planing (SRP). This therapeutic concept 
has proven to be the gold standard approach in the treatment of chronic periodontitis 
(Sanz 2012). Its efficacy is well documented in a plethora of studies (Badersten 1981, 
1984; Lindhe 1984; Kaldahl 1988).  
In a large-scale retrospective study, Van der Weijden et al. (Van der Weijden 2002) 
demonstrated successful clinical outcomes such as probing depth reduction and gain of 
clinical attachment after subgingival debridement. Furthermore, a meta-analysis 
conducted by Hung et al. demonstrated the positive effects of SRP in the reduction of 
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probing depth and stabilization of attachment loss, after treatment of medium and deep 
periodontal defects (Hung 2002). Analyses of subgingival plaque samples revealed 
alterations in the composition of subgingival microflora after SRP (Mousquès 1980; 
Müller 1986). Particularly, Haffajee et al. confirmed a decrease in prevalence of P. 
gingivalis and other periopathogenic bacteria at sites of improved periodontal 
attachment levels post-therapy (Haffajee 1997) However, histological analyses of 
healed periodontal tissues reveal in most of the cases the presence of an epithelial lining 
along the treated root surfaces of the teeth, instead of true periodontal regeneration 
(Caton 1993). Moreover, it has been showed that clinical outcomes of SRP may vary 
greatly and are dependent on several parameters such as the extent and severity of 
disease and patient's compliance with plaque control (Page 1997; Sanz 2012). 
Technological advances and a better understanding of the biology of periodontal tissues 
enabled the introduction of modifications in standard periodontal treatment. New 
debridement technologies (Tunkel 2002), full-mouth disinfection protocols (Quirynen 
1995) antibiotic administration (Haffajee 2003), implantation of autografts, allografts 
and alloplastic materials (Sculean 2008), chemical root conditioning (Maruyama 2008), 
growth factors (Raja 2009) and guided tissue regeneration (Sculean 2004) represent 
some of the therapies or techniques that have been introduced in the conventional 
periodontal treatment protocol (Fig. 1.1.4). These adjunctive methods used either alone 
or in combination may result in some cases in histological evidence of bone repair 
(Sculean 2008). However, the results in clinical applications are marginal and vary 
greatly, depending on the anatomy of periodontal defects or the amount of resident vital 
periodontal ligament (Blumenthal 1993). In conclusion, these advanced therapeutic 
interventions have proved to be insufficient to attain complete and predictable 
regeneration of the periodontium (Becker 1999; Bartold 2000; Chen 2010). 
 
 
 
Figure 1.1.4 Schematic illustration of guided tissue regeneration technique (Chen 2010). 
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1.1.5 Rationale for regenerative periodontal therapy  
In recent years, great improvement has been made in understanding the cellular and 
molecular events involved in the formation and regeneration of periodontal tissues. 
Interestingly, it has been demonstrated that dental tissues contain populations with 
characteristics of postnatal stem cells (Hynes 2012). The identification of these 
multipotent cells has stimulated interest in the potential use of cell-based therapies as 
prospective alternatives to existing therapeutic approaches for the repair and 
regeneration of the periodontium (Bartold 2006). 
Aim of regenerative periodontal therapy is the predictable restoration of the 
periodontium, including the formation of periodontal ligament, cementum with 
inserting periodontal ligament fibres and alveolar bone that have been lost due to 
periodontal disease or dental trauma (Polimeni 2006). From a biological perspective, 
one of the critical requirements for successful therapeutic approaches is the 
repopulation of the periodontal wound by ex vivo expanded progenitor populations or 
the mobilization of endogenous progenitor cells capable of promoting regeneration 
(Ivanovski 2006). 
Dental-derived stem cells are putative candidates for restoration of the complex 
ultrastructure and the dynamic function relationships between the periodontal 
components that are important for normal tissue homeostasis. Numerous animal studies 
have proved the regenerative potency of these cell populations in vivo (Trofin 2013).  
However, one of the growing concerns in dental research is the exposure of dental-
derived progenitor cells to the endotoxin-rich microenvironment of periodontal pockets 
(Morsczeck 2012). This may affect many cell properties such as self-renewal, 
differentiation potential, production of cytokines and extracellular matrix (ECM) 
compounds secretion. Moreover, Sorrell and Caplan demonstrated that multipotent cell 
grafts might trigger regenerative processes through direct commitment together with 
paracrine communication with resident cell populations and infiltrating inflammatory or 
antigen-presenting cells (Sorrell 2010). These interactions provide a regenerative 
microenvironment for destructed adult tissues to limit the area of damage and to impel a 
self-regulated regenerative response (Caplan 2007). Hence, a better understanding of 
cell behavior at sites of inflammation appears to be a key strategy for the development 
of new approaches for periodontal regeneration. 
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1.2 Human dental follicle progenitor cells 
1.2.1 Stem cells of non-dental origin 
In recent years, tissue engineering has emerged as a promising approach that could 
enable regeneration of diseased tissues, by cell transplantation with or without scaffolds 
(Langer 1993). The potential use of tissue engineering approaches are endless, and 
range from preclinical generation of cardiac valve substitutes, to ex vivo construction of 
nasal cartilages, or even to whole organ substitutes such as liver (Stock 2001). Beside 
the restricted actual clinical feasibility, pilot studies highlight great prospects for future 
stem cell-based tissue engineering techniques. This progress is mostly attributed to the 
advances in stem cell biology and recognition of the unique biological properties of 
stem cells (Eberli 2006). 
 
 
 
Figure 1.2.1 Graphic illustration of the two main characteristics of stem cells. 
 
Stem cells are defined by their capacity to self-renew and differentiate into multiple cell 
lineages (Fig. 1.2.1). One of the most studied adult stem cell types are mesenchymal 
stem cels (MSCs) (Pittenger 1999). Friedenstein et al. first described bone marrow stem 
cells (BMSCs) as a heterogeneous population of multipotent cells derived from bone 
marrow aspirates with the ability to adhere to plastic surfaces and form colonies of 
fibroblastic-like cells within the first days of cultivation (Friedenstein 1970, 1976). 
Although MSCs were originally isolated from bone marrow, similar populations of 
mesenchymal precursors were isolated from other tissues, including adipose tissue (Zuk 
2001), amniotic fluid (Roubelakis 2011), fetal liver (Fiegel 2006) and umbilical cord 
 
Self-renewal 
Differentiation 
Stem cell Mature cell 
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blood (Kögler 2004). Recent studies indicated that MSCs are able to differentiate not 
only into cells of the mesoderm lineage, but also into endoderm and neuroectoderm 
lineages, including neurons (Sanchez-Ramos 2000), hepatocytes (Schwartz 2002) and 
endothelia (Janeczek Portalska 2012). MSCs can be easily isolated and have a high 
expansion potential and genetic stability giving unlimited pool of transplantable cells 
(Wang 2012). In addition, MSCs are able to migrate to sites of tissue injury and have 
immunosuppressive properties that can be crucial for successful autologous as well as 
heterologous transplantations (Le Blanc 2005). MSCs are already utilized in several 
fields of regenerative medicine. Indeed, MSCs have been successfully integrated in 
orthopaedic therapeutical interventions facilitating the repair of bone (Mankani 2001) 
and cartilage (Murphy 2003). Furthermore, BMSCs have been proposed as candidates 
for cell-based cardiac regeneration therapies (Stamm 2003; Tongers 2011; Donndorf 
2013). 
Although human BMSCs are not isolated from oral tissues, they have already been 
extensively studied as putative candidates regarding the regenaration of periodontal 
tissues. Kawaguchi et al. observed in an animal model that BMSCs transplanted into 
Class III furcation lesions, were able to form new cementum, bone and periodontal 
ligament in the periodontal osseous defects (Kawaguchi 2004). In an in vivo study, 
Hasegawa et al. used BMSCs labeled with green fluorescent protein, and confirmed that 
after transplantation BMSCs could survive and differentiate into periodontal tissue cells 
(Hasegawa 2006). It has been proposed that BMSCs are able to sense biological signals, 
interact with the local microenvironment and contribute to the regeneration of 
periodontal tissues (Yang 2010). Clinical trials using autologous BMSCs 
transplantation in periodontal defects combined with platelet-rich plasma showed 
positive clinical outcomes (Yamada 2006). However, these approaches require an 
invasive bone marrow aspiration procedure in a secondary clinic and are associated 
with donor site complications (Chen 2012). 
Apart from bone marrow, adipose-derived stem cells (ASCs) have also been 
investigated in periodontal regeneration studies. ASCs exhibit stable growth kinetics in 
vitro and possess multilineage differentiation ability, while having similar phenotype 
and genotype to those of BMSCs and DPSCs at the transcriptional level (Hung 2011) 
(Izadpanah 2006; Zhu 2008). Several animal models have already confirmed the 
potential of ASCs to promote periodontal regeneration in situ (Tobita 2008, 2010). 
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The use of embryonic stem cells (ESCs) has been newly proposed as an alternative 
source for regenerative medicine, because of their combined abilities of unlimited 
expansion and pluripotency. The differentiation capacity of human ESCs towards 
periodontal ligament cells were recently evaluated in vitro (Inanç 2009). However, the 
clinical application of these unique cell types raises serious ethical and safety concerns. 
Finally, the induced pluripotent stem cell (iPSCs) technology represents a major hope 
associated with the development of personalised cell therapies for treating human 
disease, as periodontitis (Hynes 2013). This technological advance allows the 
generation of pluripotent cells by nuclear reprogramming of adult cells via genetic 
manipulation or introduction of multiple transcription factors (Takahashi 2006; Huangfu 
2008). Duan et al. have recently demonstrated that iPSCs combined with enamel matrix 
derivatives (EMD) could be valuable candidates for periodontal tissue engineering 
approaches (Duan 2011). Alternative approaches, as the newly proposed method of 
stimulus-triggered acquisition of pluripotency (STAP), could enhance these therapeutic 
attempts. STAP technology is based on cell nuclear reprogramming triggered by 
external stimuli such as a transient low-pH stressor (Obokata 2014). Nevertheless, 
researchers should overcome several biological unknowns, technical hurdles and safety 
concerns in order to integrate nuclear reprogrammed mammalian cells in clinical 
therapeutic approaches (Csete 2010). 
 
1.2.2 Dental-derived progenitor cells 
During the last decades, rapid progress in dental research has shed light on the 
molecular and cellular biology of periodontal tissue development. The identification of 
undifferentiated multipotent cells in the developing, but also in the mature periodontal 
ligament has inspired researchers to use them in cell-based regenerative approaches 
(Cho 2000). These multipotent cell populations retain the potential to differentiate into 
osteoblasts, cementoblasts and fibroblasts (McCulloch 1984). Experimental studies in 
mice suggest that periodontal ligament stem cells (PDLSCs) niches are perivascular 
sites in the periodontal ligament and adjacent endosteal spaces (Gould 1977; 
McCulloch 1987). According to an animal study in rats, Roberts et al. suggested that 
PDLSCs undergo a vascularly oriented differentiation during migration to the bone and 
cemental surfaces (Roberts 1987). Apart from resident PDLSCs, ex vivo-explanted 
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PDLSCs are, also, able to promote regeneration of typical cementum/ periodontal 
ligament-like structures (Seo 2004). 
Until now, numerous animal models have confirmed the capacity of PDLSCs to 
regenerate PDL tissues in vivo (Liu 2008b; Ding 2010). Specifically, Lang et al. 
demonstrated the formation of periodontal ligament-like connective tissues with 
orientated fiber bundles attached to both host bone and root, after replantation of 
PDLSCs-covered roots in a large animal model (Lang 1995). Kim et al. conducted in 
vivo studies providing further insides in the sequential histological changes during 
periodontal tissue regeneration by hPDLSCs (Kim 2012). Based on these promising 
preclinical results, PDLSCs were first candidates for tissue engineering techniques.  
At present, PDLSCs, as well as BMSCs, are used as main cell sources for periodontal 
regeneration (Feng 2010; Hoogduijn 2013). Nevertheless, the results of such 
therapeutical interventions remain marginal and unpredictable. Interestingly, recent 
findings suggest that PDLSCs proliferation and differentiation potential may be 
influenced by donor age and microenvironment factors (Zheng 2009). Such 
observations highlight the need of cautious interpretation of study results. Further 
elucidation of the molecular mechanisms governing stem cell differentiation could 
improve cell-mediated therapeutical approaches against periodontal disease (Chen 
2012). 
Newly identified dental-derived stem cells have been proposed as alternative cell 
sources. In particular, multipotent cells have been successfully isolated from several 
dental tissues as dental pulp (Gronthos 2000), dental follicle (Morsczeck 2005), 
exfoliated deciduous teeth (Miura 2003) and root apical papilla (Sonoyama 2006). A 
plethora of in vitro and in vivo studies on dental-derived stem cells provide evidence of 
their multi-differentiation capacity and their potential role in periodontal regeneration 
(Chen 2012). 
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1.2.3 Dental follicle progenitor cells  
Advances in the field of periodontal regeneration facilitated the development of cell-
based periodontal therapies. Recently identified dental-derived stem cells have been 
proposed as putative candidates for such therapeutical approaches. Specifically, dental 
follicle stem cells represent a population of precursor cells originating from the loose 
ectomesenchyme-derived connective tissue sac that surrounds the developing tooth 
germ prior to eruption (Ten Cate 1997). After the extraction of impacted third molars, 
dental follicles are commonly discarded as medical waste. However, DFPCs can be 
isolated from extracted dental follicles for research purposes, thus representing an easily 
accessible cell source. 
 
 
 
Figure 1.2.3 Panoramic radiograph of a 17 years old patient showing wisdom tooth follicle. 
Dental follicle is considered as a source of multipotent cells with the ability to generate 
all periodontal tissues, namely cementum, bone and PDL (Honda 2010). These 
precursor cells are present in dental follicle at various stages of differentiation (Luan 
2006; Yao 2008). Handa et al. first reported the presence of progenitor cells in animal 
dental follicle. In their study, cultured bovine dental follicle progenitor cells (DFPCs) 
were able to form cementum tissues and fibroblasts in vivo (Handa 2002). In 2005, 
Morsczeck et al. were able to isolate multipotent cells from dental follicles of human 
impacted third molars and described their stem cell characteristics (Morsczeck 2005). 
Subsequent investigations on human and animal DFPCs shed light to their regenerative 
potential. In particular, several studies demonstrated that DFPCs have a fibroblast-like 
morphology, are plastic-adherent and show excellent proliferation rates (Guo 2012). 
Until now there is no rigid expression pattern of stemness-related genes (Kemp 2005). 
Nevertheless, a broad set of markers has been proposed to define stem cell cultures. 
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Similar to other stem cell populations, DFPCs express CD10, CD13, CD29, CD44, 
CD53, CD59, CD73, CD90 and CD105, and do not express CD34, CD45, or HLA-DR 
(Lindroos 2008; Huang 2009). Demonstration of self-renewal ability and multilineage 
differentiation capacity are additional indications of stem cell phenotype. Indeed, it has 
been proven that DFPCs are able to form single cell-derived colonies and differentiate 
into several lineages, when induced by special media in vitro (Yao 2008). 
Moreover, the regeneration potential of DFPCs has been supported by a series of animal 
experiments. Recently, Yokoi et al. demonstrated in an animal model the ability of 
DFPCs to regenerate the periodontal ligament in vivo (Yokoi 2007). Further, Guo et al. 
investigated the potential of dental follicle stem cells to contribute to the formation of 
the tooth root (Guo 2012). Interestingly, DFPCs combined with treated dentin matrix 
(TDM) scaffolds contributed to the formation of root-like tissues with a pulp-dentin 
complex and a periodontal ligament connecting a cementum-like layer to host alveolar 
bone (Guo 2012). Recent data indicate that dental follicle cells induced by Hertwig’s 
epithelial root sheath cells may form periodontal tissues in vivo through epithelial-
mesenchymal interactions (Bai 2011). However, the mechanisms governing DFPCs 
regeneration potency remain to be elucidated.  
 
1.3 Porphyromonas gingivalis 
1.3.1 General characteristics 
Porphyromonas gingivalis (formerly Bacteroides gingivalis) is a Gram-negative, non-
motile, asaccharolytic bacterium. It requires anaerobic conditions for growth, exhibits 
both cocco-bacillary to short rod morphologies and forms smooth to rough colony 
morphotypes (Reynolds 1989; Haffajee 1994). The species belongs to the black-
pigmented Bacteroides group and can form brown to black colonies when cultured in 
blood agar plates (Oliver 1921). The black pigmentation of P. gingivalis colonies is 
correlated to the accumulation of hemin (oxidized form of heme) on its cell surface (Liu 
2004; Smalley 2008). Furthermore, it is postulated that heme has a profound effect on 
virulence of P. gingivalis, as when grown under hemin-limited conditions, it becomes 
less virulent (McKee 1986; Lewis 1999).  
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When considering its role in the establishment of multispecies subgingival biofilm 
communities, P. gingivalis is classified as a late colonizer, capable to adhere to oral 
surfaces and interact synergistically with antecedent biofilm inhabitants (Capestany 
2008; Kolenbrander 2011). The species is intensively invasive, as demonstrated in 
several in vitro studies (Sandros 1993; Weinberg 1997; Houalet-Jeanne 2001). 
Particularly, P. gingivalis is able to invade and remain viable in host cells (Andrian 
2006; Amano 2007), while suppressing host cell apoptosis (Yilmaz 2008; Yao 2010). 
The major ecological habitat of P. gingivalis is the gingival sulcus. Moreover, the 
organism can be detected in tongue coat, tonsils, oral mucous membranes and saliva 
samples (Zambon 1981; Danser 1996; Tanaka 2004). In addition to the oral niches, P. 
gingivalis can also spread systemically and be found in distant sites as demonstrated for 
atheromatous plaques (Kozarov 2006), osteomyelitis lesions (Welkerling 2006), 
amniotic cavity (León 2007), respiratory tract (Scannapieco 1999; Mojon 2002) and 
cerebrospinal fluid (Iida 2004). 
Therefore, the biological significance of the species has been in focus of research in the 
last decades. The potential effects of P. gingivalis on several host cell types, including 
not only oral epithelial cells and fibroblasts, but also dendritic cells, macrophages, 
neutrophils, endothelial cells have been extensively discussed in previous reviews 
(Kantarci 2002; Amano 2003; Bélanger 2006; Cutler 2006; Hajishengallis 2007; Kinane 
2008; Sheets 2008; Yilmaz 2008). The impact of several perio-pathogenic bacteria, as 
P. gingivalis, on BMSCs and dental-derived stem cells has been recently demonstrated, 
thus revealing new insights into the interactions between live bacteria and multipotent 
stem cells (Kriebel 2013). 
 
1.3.2 Association with periodontal disease  
The oral cavity is habitat for a plethora of bacterial species. Specifically, it is estimated 
that the oral microflora consists of more than 700 different bacterial species, which 
normally coexist in commensal harmony with the host (Moore 1994; Aas 2005). 
Despite the enormous diversity of the oral microbiome, only some of these species are 
considered to have an impact on the initiation and progression of periodontitis (Paster 
2006). 
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In recent years, the use of advanced techniques for identification of microorganisms, in 
combination with the relative non-invasive nature of sampling, facilitated the 
conduction of thorough analyses of the oral microbiota in both health and disease 
(Haffajee 2008). These studies led to the identification of P. gingivalis as a major 
contributor to periodontal disease and member of the ‘red complex’ pathogens, 
comprising T. forsythia and T. denticola (Socransky 1992; Lamont 1998; Holt 2005). 
Specifically, several studies based on in vivo experimental models demonstrated that P. 
gingivalis may induce dysbiosis, or a microbial shift in the commensal composition, 
ultimately leading to periodontitis (Baker 2000; Page 2007; Hasturk 2007; 
Hajishengallis 2011). Increased incidence of P. gingivalis is positively correlated to 
destructive forms of periodontal disease (Van Winkelhoff 2002; Kawada 2004). 
Besides, reduced levels of P. gingivalis are associated with clinical improvement at 
diseased sites after periodontal treatment (Haffajee 1997; Takamatsu 1999; Ximénez-
Fyvie 2000; Fujise 2002). 
Even though a large body of evidence on the pathogenic role of P. gingivalis in disease 
formation exists, the pathogenesis of infection is still not fully understood (Yilmaz 
2008). Hence, the proposed idea of using P. gingivalis as a prognostic marker for 
periodontitis is open to dispute (Leonhardt 2011). Remarkably, studies on the 
composition of subgingival species in or on the sulcular gingival epithelial cells showed 
no significant differences in the levels of P. gingivalis in the epithelial samples obtained 
from healthy or diseased subjects (Colombo 2006, 2007). Indeed, it has been recently 
proposed that the oral epithelium of healthy subjects, may exhibit a natural tolerance 
towards oral microbiota (Jump 2004; Rudney 2006). Parallely, the notion that P. 
gingivalis may act as an opportunist, that under certain circumstances is able to subvert 
host defence, is now well established (Bostanci 2012). In conclusion, the sophisticated 
mechanisms behind the reciprocal interactions between perio-pathogenic bacteria and 
host cells appear to be highly complex and remain to be elucidated (Curtis 2005; 
Yilmaz 2008). 
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1.3.3 P. gingivalis LPS 
It is widely accepted that P. gingivalis produces a range of potential virulence factors. 
These exhibit multiple functions and are part of the proposed survival strategies of P. 
gingivalis into the host (Holt 2005). Specifically, a major virulence factor of P. 
gingivali  is its capsular polysaccharide (CPS), also known as K-antigen (Brunner 
2010). It is demonstrated to be involved in the modulation of host immune mechanisms 
by circumvention of phagocytosis (Singh 2011). Further, gingipains of P. gingivalis are 
extracellular cysteine proteases, also present in soluble form (Bostanci 2012). 
Gingipains are demonstrated to possess proteolytic and adhesion domains and are 
involved not only in the degradation or cleavage of host cell proteins, but also the 
attachment of P. gingivalis to the tissues (Potempa 2000; Curtis 2005; Sheets 2008). 
Adhesins such as fimbriae, haemagglutinins, a putative invasin (haloacid dehalogenase 
family phosphoserine phosphatase) and a variety of toxic by-products (e.g. ammonia) 
are also included in the panel of the organism virulence factors (Yilmaz 2008). 
The major component of the outer membrane of P. gingivalis is LPS, an endotoxin and 
common characteristic of all Gram-negative bacteria. The long polysaccharide chains of 
LPS are able to stimulate the complement system and provoke the release of pro-
inflammatory molecules, thus initiating host immune responses (Siqueira 2007). 
Moreover, LPS plays a crucial role in maintenance of bacterial structural integrity and 
establishment of selective permeability barrier to noxious compounds or nutrient 
molecules (Shoji 2002; Nikaido 2003). Therefore, LPS is supposed to be essential for 
the survival of P. gingivalis within host cells (Jain 2010).  
Structurally, LPS comprises three domains: an O-antigen, a core oligosaccharide (OS) 
and lipid A. The O-antigen may be a long polysaccharide that comprises the outermost 
domain of the LPS molecule and forms the external surface of the bacterium. The 
structure of O-antigen is highly variable and immunogenic. Thus, O-serotyping is used 
to distinguish between sub-species of bacteria according to O-antigen composition 
(Sims 2001). The core OS contains a vast variety of glycoforms and is typically 
composed of two domains, the outer and inner core being directly attached to the O-
antigen and lipid A, respectively (Paramonov 2009). The inner-most component of 
LPS, the hydrophobic lipid A, is embedded in the bacterial outer membrane of Gram-
negative cell wall and serves as an anchor for LPS. It is suggested that P. gingivalis 
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lipid A may be responsible for the strong innate immune response at sites of infection 
(Wang 2002). Interestingly, P. gingivalis is able to synthesize a variety of lipid A 
structures, as result of its exposure to several environmental conditions. Thus, it is 
demonstrated that high concentrations of hemin, at sites of severe periodontal 
inflammation may provoke the production of antagonistic lipid A that is able to activate 
host cell receptors (Jain 2010). Hence, the heterogenous structure of lipid A could 
explain the binding of P. gingivalis LPS to several cognate TLR receptors and the 
activation of differential immune signalling pathways (Bostanci 2012).  
 
1.3.4 Target cell receptors of P. gingivalis LPS 
In general, cells recognize the presence of bacteria and bacterial components via so-
called pattern recognition receptors (PRRs). Specifically, PRRs sense typical patterns of 
microbial molecules, known as pathogen-associated molecular patterns (PAMPs) 
(Janeway 1989). Toll-like receptors (TLRs) are the first identified and best-
characterized group among the human PRRs. The family of TLRs contains to date 10 
members in humans (Staquet 2011). TLRs are type I transmembrane proteins and are 
able to recognize a wide range of PAMPs (Kawai 2011). Upon PAMP engagement, 
TLRs are able to trigger transcriptional or post-translational cellular responses (Vance 
2009). In fact, P. gingivalis LPS may induce the production pro-inflammatory cytokines 
such as tumor necrosis factor alpha (TNF-α), interleukin-1 (IL-1), IL-6, and IL-8 in host 
cells (Wang 2002; Zhou 2005; Hamedi 2009). Especially, LPS sensing via TLRs is 
considered to play a critical role in signal transduction at sites of periodontal 
inflammation (Wang 2002). 
Two members of the Toll-like receptor family, TLR2 and TLR4, have been identified 
as possible signaling receptors of P.gingivalis LPS (Darveau 2004). These receptors 
have been detected in gingival epithelium and connective tissue samples (Beklen 2008). 
Moreover, TLR2 and TLR4 are demonstrated on many cell types including immune 
cells, macrophages and dendritic cells (Schuman 1990; Wright 1990; Flo 2001; Kaisho 
2002). According to a large body of evidence, TLR4 is documented as a specific 
receptor for most bacterial LPS (Noreen 2012). Particularly, several in vitro and in vivo 
experimental studies have demonstrated P. gingivalis LPS as potent agonist of TLR4 
(Ogawa 2002; Sawada 2007; Kumada 2008; Zhang 2008). Further, TLR2 has been 
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identified as a predominant receptor for P. gingivalis LPS, even though it is mainly 
involved in the recognition of lipoproteins, lipoteichoic acid and peptidoglycans 
(Siqueira 2007). Interestingly, in vivo studies in TLR2 or TLR4 knock-out mice 
demonstrated the induction of bone loss after P. gingivalis treatment via TLR2, but not 
TLR4 (Hirschfeld 2001; Burns 2006). On the contrary, other experimental studies 
suggested the activation of both TLR2 and TLR4 which, nevertheless, can lead to 
activation of different signalling cellular cascades (Bainbridge 2001; Zhou 2005). These 
contradicting results could be explained by the ability of P. gingivalis to alter its lipid A 
structure. This LPS modification could modulate its binding affinity to TLRs resulting 
in opposing host innate immune responses and increased survival chance for the species 
(Bostanci 2012). 
 
1.4 Hypothesis statement 
The rapid advancements in the field of dental research over the last few years could 
deliver the promise of tissue regeneration through stem cells. The demand for novel 
therapies against inflammatory diseases, like periodontitis, has created the need for a 
better understanding of the behaviour of progenitor cells in sites of bacterial infection. 
Specially, P. gingivalis has been considered as protagonist in the initiation and 
development of inflammatory processes leading to periodontitis (Hamada 1994; Tobias 
1997). Particularly, P. gingivalis LPS is supposed to able to stimulate inflammatory 
cytokine production and bone resorption. Most studies on cellular effects of 
periodontopathic bacteria focused on gingival fibroblasts (Wang 2002; Tardif 2004; 
Herath 2011) and periodontal ligament cells (Seo 2012), which are mostly involved in 
the remodelling of the periodontium. Also osteoclasts, a key cell population involved in 
bacteria-induced bone destruction, have been in focus of research (Chen 2001; Scheres 
2011). Nevertheless, only few studies have been done so far investigating the influence 
of bacterial components on osteoblast progenitors (Loomer 1994, 1995; Kadono 1999). 
Further, Chang et al. investigated dental pulp stem cells treated with LPS and detected 
activation of NF-κB (Chang 2005), while Yamagishi et al. analyzed the effects of 
P.gingivalis LPS on dental pulp stem cell differentiation ability (Yamagishi 2011). Till 
now most studies on DFPCs have focused on cell characterization and tissue 
regeneration potential (Bai 2011; Jung 2011; Guo 2012; Yang 2012). Nevertheless, 
little is known about the impact of bacteria on DFPCs properties. 
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Here we hypothesized that DFPCs are able to sense and respond to P. gingivalis LPS. 
Further, DFPCs responses were speculated to be differential in comparison to other 
populations of multipotent cells. Aim of the study was to investigate the possible 
influence of LPS on cell proliferation, gene expression, wound healing capability and 
cytokine production of DFPCs. In this context, DFPCs were compared with early 
passages of bone marrow-derived stem cells (BMSCs), a well-studied class of adult 
stem cells. 
 
 
 
Figure 1.4 Experimental design of the study. 
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2. Materials and Methods 
2.1 Cell isolation and culture 
2.1.1 Isolation and culture of human DFPCs and BMSCs 
Human impacted third molars (n = 6) were surgically removed and collected from 
patients (aged 17 to 23 years) at the Rostock university school of dental medicine. 
Patient inclusion and exclusion criteria are shown in Table 2.1.1. Patients must have 
met all the criteria to be eligible for participation in the study. Written informed consent 
was obtained from all patients or their legally authorized representatives, following 
approved guidelines set by the commission of ethics of Rostock university school of 
medicine (Reg.Nr: A 2010 87). 
       Inclusion criteria 
- patients had to be between fifteen (15) and twenty five (25) years old 
- patients required surgical extraction of impacted third molars because of medical reasons 
independent of this research project 
       Exclusion criteria 
- patients with wisdom teeth under periodontal or endodontic treatment 
- patients with developmental dental anomalies (e.g. tooth fusion or genimation) 
- patients having any systemic diseases (e.g. diabetes mellitus) 
 
Table 2.1.1 Patient inclusion and exclusion criteria. 
Teeth extractions were conducted under local anesthesia by a team of two cooperating 
oral surgeons. After elevation of a full-thickness flap, maxillar/ mandibular bone over 
the impacted teeth was excised by round diamond burs (head dia 2.3 to 2.9 mm) under 
irrigation with sterile saline, to prevent tissue damage. During sample collection, 
operators avoided contact with oral mucosa thus minimizing bacterial contamination 
risks. The freshly extracted tissues were immediately placed into sterile plastic tubes 
containing ice-cold basic culture medium (aMEM) supplemented with 1% of penicillin 
streptomycin and transferred to the laboratory within 30 minutes in a sealed plastic box. 
On arrival at the laboratory the specimens were placed in 60 mm tissue culture dishes 
for further manipulations under aseptic conditions provided by a laminar flow cabinet. 
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Dental follicles were separated from teeth by the use of sterile curettes and a pair of 
fine-tipped forceps. After extensive washes with PBS, follicle tissues were minced into 
0.5 to 2 mm pieces with a single-use scalpel and digested in culture medium 
supplemented with 0.1 U/ mL collagenase and 0.8 U/ mL dispase for 1 hour at 37°C. 
Explants were then transferred to T-25 cell culture flasks and cultivated in a 
mesenchymal stem cell growth medium (MSCGM) at 37°C in a 5% CO2 humidified 
atmosphere. Single cells attached to the plastic surface within 24 hours and non-
adherent cells were removed by gently washing the plates three times with PBS. 
Finally, fresh culture medium was added and cells were left for incubation (Fig. 2.1.1). 
 
 
 
Figure 2.1.1 Schematic overview of DFPCs isolation procedure. 
 
Human mesenchymal stem cells processed from bone marrow aspirates of human adult 
volunteers (n = 8) were generously provided by the Reference and Translation Center 
for Cardiac Stem Cell Therapy (RTC) at Rostock University. Informed consent was 
obtained from all patients according to the Declaration of Helsinki. BMSCs were 
isolated according to the standard isolation protocol of the RTC laboratory (Gaebel 
2011). After isolation, BMSCs were cultivated in MSCGM under standard culture 
conditions and served as an experimental control group. 
 
Material description Type Company 
articain solution Ultracain 2% DS Sanofi-Aventis 
round diamond burs  2.3 to 2.9 mm dia Komet Dental 
scalpel blade  Nr 10, 15 Henry Schein Dental 
scalpel handle 12.5 cm length Henry Schein Dental 
root elevator 2mm round-tip Henry Schein Dental 
tissue 
extraction 
enzymatic 
digestion 
DFPCs 
isolation 
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Material description Type Company 
periosteal elevator 6.5 mm round-tip Henry Schein Dental 
gracey curette 1/2 Hu-Friedy 
collagenase / dispase 0.1 U/mL / 0.8 U/mL Roche 
cell culture flasks  Cellstar, T-25 Greiner Bio-One 
petri dishes Cellstar, 60 mm dia Greiner Bio-One 
penicillin 100 U/ mL PAA 
streptomycin 100 μg/ mL PAA 
αMEM with L-Glutamine  PAN-Biotech 
MSCGM culture medium Lonza 
PBS with Ca and Mg PAN-Biotech 
 
 
2.1.2 Cell culture of human DFPCs and BMSCs 
Cell culture was performed under sterile conditions in a 5% CO2 incubator at 37 °C. All 
cell culture manipulations were done under a laminar flow hood. Work surfaces were 
wiped down with 70% ethanol before and after each use. Inside the hood all work was 
done with sterile pipette tips. All supplies and reagents that came into contact with the 
cell cultures were sterile. Solutions were divided into small aliquot tubes whenever 
possible in order to reduce the possibility of microbial contamination. Cultures were 
inspected every 2 to 3 days under a phase contrast microscope (magnification 400x) for 
signs of contamination. Any contaminated cell cultures were immediately discarded. 
Cells seeded in culture flasks grew in mesenchymal stem cell growth medium 
supplemented with 1% of penicillin and streptavidin. Culture medium was replaced 
every 2 to 3 days until cells reached 70 - 80% optical confluence. In order to produce 
large number of cells for the subsequent experiments, cell passaging was required. 
Thus, culture media were removed from flasks and cells were washed twice with PBS. 
Pre-warmed 0.05%/ 0.02% (w/ v) trypsin/ EDTA solution was added and cells were 
incubated for 7 minutes to detach. After incubation, a 9fold volume of pre-warmed 
culture medium was added to stop trypsin reaction and cells were carefully resuspended 
to a single cell suspension. Then cell suspension was transferred to a 15 mL conical 
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tube and centrifuged at 300 g for 10 minutes. After centrifugation, supernatants were 
removed and cells were aspirated and resuspended in fresh culture medium. Cell 
number was determined with a hemocytometer. For that 10 µL of cell suspension was 
stained with trypan blue (0.4% w/ v in PBS) and introduced into the sink of the 
chamber to be counted under the microscope (100x magnification). Cell number was 
calculated according to the following formula: C = N x D x 10 
4
, where C stands for the 
number of viable cells/ mL, N is the average number of viable cells counted in 10 
subgrids (1.0 mm³), D is the dilution factor, and 10 
4
 is the hemocytometer correction 
factor. After counting cells were placed into new flasks at a density of 200 cells/ cm². 
Cells from passages 1 to 3 were used for the subsequent in vitro experiments. 
 
Material description Type Company 
laminar flow hood Herasafe Thermo Scientific 
centrifuge Heraeus Multifuge 1 SR Thermo Scientific 
hemocytometer T728.1 Carl Roth 
Trypan bleu solution, 0.4% Sigma-Aldrich 
mikroscope DMLB Leica 
cell culture flasks  Cellstar, T-75/ -125 flasks  Greiner Bio-One 
cell culture tubes  polystyrene, 15/ 50 mL Greiner Bio-One 
aliquot tubes safe - lock, 0.5/ 1.5/ 2 mL Eppendorf 
trypsin/ EDTA 0.05% / 0.02% (w/ v) PAA 
carbon dioxide incubator APT.Line CB Binder 
mikroscope Axiovert 40 CFL Carl Zeiss 
water bath W6 Medingen 
gloves KC500 purple nitrile Kimberly-Clark 
pipettes  Research, 0.5 - 1000 μL Eppendorf  
pipettor Easypet Eppendorf 
pipette tips Cellstar, 10 μL – 25 mL Greiner Bio-One 
ethanol solution, 70 % University Central Pharmacy 
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2.1.3 Cryopreservation of cells 
Cryopreservation was used for creating cell stocks ready for use in the subsequent 
experiments. Prior to cryopreservation cells were trypsinized and cell suspensions were 
processed for cell counting. After determining viable cell density, cells were transferred 
to 15 mL tubes and were pelleted by centrifugation at 300 g for 7 minutes at 24°C. Then 
cell pellets were resuspended in freezing solution consisting of 10% DMSO and 
transferred to 2 mL labeled cryogenic vials at a concentration of 10
6
 cells per mL. The 
aspiration of cells in DMSO supplemented solution before freezing is critical for the 
prevention of cell damages due to ice crystal formation. According to a slow rate 
cooling protocol cryovials were placed upright for 4 hours in a -20°C freezer before 
being transferred to a -80°C freezer. After at least 24 hours in the -80°C freezer, cells 
were finally transferred to liquid nitrogen for long-term storage. 
To thaw frozen cell suspensions, cryovials containing cells were rapidly thawed by 
submersion in a 37°C water bath for 1 - 2 minutes with constant agitation. Rapid 
thawing was critical because it prevented the recrystallization of ice crystals as the 
temperature rose, thus enhancing cell viability after cryopreservation (Seki 2008). 
Thawed cell solutions were transferred to sterile 15 mL tubes containing 9 mL of pre-
warmed culture medium, pelleted at 300 g for 10 minutes at 37°C and resuspended in 5 
mL of fresh culture medium.Then cell suspensions were transferred to T-75 cell culture 
flasks containing 10 mL of medium and were cultured under standard culture 
conditions. 
 
Material description Type Company 
cryogenic tubes Nunc CryoTubes Sigma-Aldrich 
cell freezing medium Gibco’s Recovery Invitrogen 
laboratory freezer set at –20°C Kirsch 
laboratory freezer set at –80°C  Kirsch 
water bath W6 Medingen 
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2.2 In vitro cell characterization  
After isolation by plastic adherence, DFPCs and BMSCs were characterized in vitro 
based on morphology, clonogenic potency, proliferative activity, multilineage 
differentiation capacity and expression of a specific set of cell surface marker proteins 
(Fig. 2.2).  
 
 
Figure 2.2 Overview of in vitro cell characterization. 
 
2.2.1 Colony forming assay 
Human DFPCs and BMSCs at passage 1 were cultured to sub-confluence. After 
counting, single-cell suspensions were seeded at low densities (30 cells per cm²) into 6-
well plates. Cells were cultured in MSCGM to form colonies. Culture medium was 
replaced every 3 to 4 days and cells were monitored microscopically for overgrowth. 
After 12 days of incubation, culture medium was removed; cells were fixed with 4% 
PFA for 10 minutes at room temperature and subsequently washed with distilled water. 
The total number of colonies was determined microscopically, by scoring aggregates of 
more than 50 cells. Percentages of colony-forming efficiency (CFE) were calculated as 
follows: 
CFE (%) = (no. of colonies formed/ no. of cells seeded) x 100% 
 
Material description Type Company 
cell culture flasks  Cellstar, T-75/ -125 flasks  Greiner Bio-One 
MSCGM Culture medium Lonza 
PFA powder Sigma-Aldrich 
mikroscope Axiovert 40 CFL Carl Zeiss 
cell culture cell isolation 
cells 
Plastic adherence 
Morphology 
Clonogenic potency 
Proliferative activity 
Differentiation capacity 
Surface marker expression 
 
 
 
 
 
 
Dental follicle 
Bone marrow 
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2.2.2 3-2, 5-Diphenyltetrazolium bromide (MTT) dye reduction assay 
Cell metabolic activity was determined by MTT assays. Single-cells were seeded in 96-
well plates at a density of 1 x 10
3
 cells per well in MSCGM. Wells containing only 
culture medium served as blank controls for non-specific dye reduction. For 
measurement, 200 µL MTT solution was added to each well to a final concentration of 
0.5 mg/ mL. After 4 hours of incubation at 37°C, culture medium was removed and 
purple formazan crystals were dissolved in 100 µL DMSO. Absorbance was measured 
at 550 nm (test wavelength) and 655 nm (reference wavelength) using a microplate 
reader. Raw data were expressed as percentages of viability according to the following 
formula: 
Cell viability (%) = (OD550 – OD655, sample/ OD550 – OD655, control) x 100% 
 
Material description Type Company 
multiwell cell culture plates 96 wells Greiner Bio-One 
MSCGM culture medium Lonza 
microplate reader Model 680 Bio-Rad Lab 
MTT powder Sigma-Aldrich 
DMSO solution Carl Roth 
 
2.2.3 In vitro functional differentiation assay 
The ability of human DFPCs and BMSCs to differentiate into multiple mesenchymal 
lineages was determined using a human mesenchymal stem cell functional 
identification kit according to the instructions of the manufacturer. Observation of cell 
morphology changes and cytological staining were used to verify cell differentiation 
capacity toward three mesodermal lineages.  
According to the adipogenesis protocol sterile coverslips were inserted into wells of a 
24-well plate. Then 3.7 x 10⁴ cells were seeded in each well and were cultured in 
αMEM (0.5 mL/ well). When 100% confluency was reached, adipogenic differentiation 
was induced by culturing cells for 14 days in αMEM with 10% HSA, 1% penicillin-
streptomycin, and adipogenic supplement containing hydrocortisone, 
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isobutylmethylxanthine, and indomethacin in 95% ethanol. Adipogenic differentiation 
medium was freshly prepared and replaced (0.5 mL/ well) every 3 - 4 days. The 
appearance of lipid vacuoles could be monitored by microscopic examination 7 - 9 days 
after adipogenic induction. On 14th day adipocytes were fixed with 4% PFA (0.5 mL/ 
well) for 10 minutes at room temperature and subsequently washed twice with PBS (1 
mL/ well). 
Oil droplets in the cultures were identified by staining cells with Oil Red O. For lipid 
staining, Oil red O was diluted in 60% isopropanol for 15 minutes at 37°C and were 
filtered through a 0.2 μm syringe driven filter. Cell samples were incubated in dye 
solution (0.5 mL/ well) for 45 minutes at room temperature and then rinsed twice with 1 
mL PBS to remove redundant Oil red O, before nuclear staining with DAPI (5 minutes, 
room temperature). Then coverslips were inverted onto a microscope slide containing 
10 µL of mounting media. Excess mounting media was removed with fiber-free tissue 
wipers, without disturbing the coverslip. The edges of each coverslip were sealed with 
regular transparent nail polish and were left to dry for 10 minutes. Cells were then ready 
for microscopic viewing. Images were obtained using a light microscope with a video 
camera attachment. 
For osteogenic differentiation, 7.4 x 10³ cells were seeded on coverslips inserted into 
wells of a 24-well plate. Cells were cultured in αMEM (0.5 mL/ well) until 50 - 70% 
confluence was reached. Then, osteogenic differentiation was induced by culturing cells 
for 14 days in αMEM  with 10% HSA, 1% penicillin-streptomycin, and osteogenic 
supplement containing dexamethasone, ascorbate-phosphate, and β-glycerolphosphate. 
Osteogenic differentiation medium was freshly prepared and replaced (0.5 mL/ well) 
every 3 - 4 days. On 14th day, osteocytes were fixed with 4% PFA (0.5 mL/ well) for 
10 minutes at room temperature and were subsequently washed twice with PBS (1 mL/ 
well). 
Calcium containing precipitates were visualized after staining with 2% aqueous 
Alizarin red S adjusted to a pH of 4.2 with ammonium hydroxide. Cell samples were 
incubated in dye solution (0.5 mL/ well) for 15 minutes at room temperature in the dark 
and then rinsed twice with 1 mL PBS to remove redundant Alizarin red S, before 
nuclear staining with DAPI (5 minutes, room temperature). Then coverslips were 
mounted on microscope slides as described above, and were examined by microscopy. 
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For chondrogenic differentiation, 25 x 10⁴ cells were transferred in a 15 mL conical 
tube for centrifugation at 200 g for 5 minutes at room temperature. Then cells were 
resuspended in 1 mL DMEM/ F-12 and centrifugated at 200 g for 5 minutes at room 
temperature. After discarding the medium, cells were resuspended in 0.5 mL of 
chondrogenic differentiation medium consisting of DMEM/ F-12 basal medium with 
1% penicillin-streptomycin, 1% ITS supplement and chondrogenic supplement 
containing dexamethasone, ascorbate-phosphate, proline, pyruvate, and TGF-β3 and 
centifugated once again at 200 g for 5 minutes at room temperature. After loosing the 
cap of the tube to allow gas exchange, pelleted cells were cultured for 21 days at 37°C 
in a 5% CO2 humidified atmosphere protected from light. Chondrogenic differentiation 
medium was freshly prepared and replaced (0.5 mL/ tube) every 2 - 3 days. After 21 
days, chondrocyte pellets were fixed with 4% PFA for 20 minutes at room temperature 
and were subsequently washed with 1 mL of PBS for 5 minutes. For frozen sectioning, 
cell pellets were cryo-embedded in tissue freezing medium and stored at -80°C. Cell 
pellets were cut by a cryostat-microtome and frozen sections (5 µm thick) were 
mounted onto microscope slides and placed in sealed slide boxes at -20°C until needed. 
Sections were stained with 0.1% aqueous Safranin O (0.5 mL/ well) to visualize 
sulfated proteoglycans. Cell samples were incubated in dye solution (0.5 mL/ well) for 
5 minutes at room temperature in the dark and then rinsed twice with 1 mL PBS to 
remove redundant Safranin O. Coverslips were then mounted on microscope slides as 
described above, and examined by microscopy for chondrogenic differentiation. 
 
Material description Type Company 
human mesenchymal stem cell functional identification kit  R & D Systems 
multiwell cell culture plates 24 wells  Greiner Bio-One 
coverslips 13mm dia Menzel 
cell culture tubes  polystyrene, 15 mL Greiner Bio-One 
αMEM with L-Glutamine  PAN-Biotech 
DMEM/ F-12 with L-Glutamiine PAN-Biotech 
HSA solution, 20%, low salt CSL Behring 
Oil Red O powder  Sigma-Aldrich 
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Material description Type Company 
Alizarin red S powder  Sigma-Aldrich 
Safranin O powder  Sigma-Aldrich 
ammonium hydroxide solution  Avantor Performance Materials 
isopropanol solution Avantor Performance Materials 
fine dosage syringe Omnifix-F B. Braun 
syringe driven filters Millex PVDF, 0.2 μm Millipore 
needles  23 Gauge BD Microlance 
Ph-meter MP220 Mettler Toledo 
mounting medium Glycergel, aqueous Dako 
tissue freezing medium Tissue-Tek Sakura Finetek 
cryostat-microtome CM 1900 Leica 
microscope slides plain Marienfeld-Superior 
tissue wipers Kimtech science Kimberly-Clark 
microscope SP2 Confocal Microscope Leica 
digital camera DC 200 Leica 
 
2.2.4 Cell staining for immunofluorescence 
The differentiation capacity toward different cell lineages was verified further by 
immunostaining for specific markers that are fatty acid binding protein (FABP-4) for 
adipocytes, osteocalcin for osteocytes and aggrecan for chondrocytes. 
Antibody Description Company  
Primary antibody goat anti-mouse FABP-4 
mouse anti-human osteocalcin 
goat anti-human aggrecan  
R& D Systems 
R & D Systems 
R & D Systems 
Secondary antibody anti-mouse AlexaFluor 488 
anti-goat AlexaFluor 488  
Invitrogen 
Invitrogen 
Nuclear stain DAPI Invitrogen 
 
Table 2.2.4 Antibodies for immunofluorescence microscopy. 
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Prior staining, cells were fixed with 4% PFA (0.5 mL/ well) for 10 minutes at room 
temperature and were subsequently washed twice with PBS (1 mL/ well). Then cells 
were washed three times with 0.5 mL of 1% HSA in PBS for 5 minutes. Prior antibody 
incubation cells were permeabilized and blocked cells with 0.5 mL of 0.3% TritonX-
100, 1% HSA, 10% horse serum in PBS at room temperature for 45 minutes. After 
blocking, cells were incubated with 300 μL/ well of antibody working solution 
overnight at 5°C. Primary antibodies were diluted in PBS containing 1% HSA and 10% 
horse serum to a final concentration of 10 μg/ mL. Negative controls were performed 
using PBS containing 1% HSA and 10% horse serum with no primary antibody added. 
Followingly, cells were washed three times with 0.5 mL of PBS containing 1% HSA for 
5 minutes and incubated with secondary antibodies (300 μL/ well) diluted in PBS with 
1% HSA at in the dark for 60 minutes at room temperature. For background staining 
control samples were incubated with secondary antibody only. After incubation cells 
were washed with 0.5 mL of PBS containing 1% HSA for 5 minutes to remove 
redundant antibodies. For nuclear staining cells were stained with DAPI (5 minutes, 
room temperature). Then coverslips were mounted on microscope slides, as described 
above, and were examined by a microscope equipped with fluorescence optics. The 
primary and secondary antibodies used in the study are listed in Table 2.2.4. 
 
Material description Type Company 
PFA powder Sigma-Aldrich 
HSA solution, 20%, low salt CSL Behring 
donor horse serum heat-inactivated, 10% PAA 
TritonX-100   solution, 0.3% Carl Roth 
microscope DMLB Leica 
digital camera DC 200 Leica 
 
2.2.5 Fluorescence-activated cell sorter analysis 
DFPCs and BMSCs were analyzed for surface marker expression by fluorescence-
activated cell sorter (FACS) analysis. Cells were detached from culture flasks, counted, 
suspended in ice-cold buffer (1x PBS supplemented with 0.5%BSA and 2mM EDTA) 
and transferred in 1.5 mL aliquot tubes (50.000 cells/ tube). Single-cell suspensions 
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were incubated for 30 minutes at 4°C protected from light with saturating levels of 
monoclonal anti-human antibodies (Table 2.2.5). For indirect marker detection, cells 
labelled with CD90-biotin were additionally incubated with V450-Streptavidin 
secondary antibody for 20 minutes at 4°C in the dark. FcR Blocking Reagent was 
employed to reduce unspecific antibody binding. Background fluorescence was 
excluded using unlabeled cells and cells incubated with isotype-matched antibodies 
(Table 2.2.5). 
Antibody Conjugate Isotype Company  
CD14 V450  mouse IgG2b   BD Biosciences 
CD29 APC mouse IgG1   BD Biosciences 
CD44  PerCP-Cy5.5 mouse IgG2b   BD Biosciences 
CD45  V500 mouse IgG1   BD Biosciences 
CD73 PE mouse IgG1   BD Biosciences 
CD90-biotin Streptavidin-V450 mouse IgG1   BD Biosciences 
CD105  Alexa Fluor 488 mouse IgG1  AbD Serotec 
TLR2 FITC mouse IgG2a   eBioscience 
TLR4 Alexa Fluor 488 mouse IgG2a    eBioscience 
 
Table 2.2.5 Antibodies for analytical fluorescence-activated cell sorting. 
 
After washing cells were transferred into FACS tubes and were analysed using a flow 
cytometer. Dead cells were excluded using a dead cell staining kit. After acquisition of 
light scattering and fluorescence data for each sample, the resulting information could 
be analyzed utilizing computer specific software that was associated with the flow 
cytometer. A minimum of 10.000 events were recorded per sample. 
Material description Type Company 
BSA lyophilized powder Sigma-Aldrich 
EDTA solution Sigma-Aldrich 
FcR Blocking Reagent  human Miltenyi Biotec 
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Material description Type Company 
LIVE/DEAD Fixable Dead Cell Stain Kit Invitrogen 
FACS tubes 5 mL polystyrene, round-bottom BD Biosciences 
Vortex mixer  Vortex Genie 2 Scientific Industries 
pipetboy acu  IBS Integra Biosciences 
flow cytometer BD FACS LSR II BD Biosciences 
data analysis software  FACSDiva 6 BD Biosciences 
 
 
2.3 LPS treatment 
After cell characterization both DFPCs and BMSCs were assayed for their ability to 
sense and respond to P.gingivalis LPS. Concretely, cells were treated with several doses 
of LPS in several time periods. Cells responses were analyzed in terms of cell viability, 
TLR2 and TLR4 expression, in vitro wound healing capacity and IL-6 secretion. 
 
 
 
Figure 2.3 Overview of in vitro cell characterization after LPS treatment. 
 
2.3.1 LPS treatment and cytotoxicity assay 
Ultrapure LPS from P.gingivalis was obtained commercially and were used at final 
concentrations of 0, 1, 10 and 50 μg/ mL in MSCGM. To determine the cytotoxic 
effects of LPS, MTT assays were performed as described above (Section 2.2.2). 
Material description Type Company 
P.gingivalis LPS ultrapure InvivoGen 
MSCGM culture medium Lonza 
LPS treatment 
P.gingivalis LPS 
Cell viability 
TLR2 and TLR4 expression 
In vitro wound healing ability 
IL-6 secretion 
 
 
 
 
Materials & Methods    34 
 
2.3.2 RNA extraction and complementary DNA synthesis 
Total RNA was extracted from cells using an RNA purification kit at room temperature 
according to the manufacturer’s instructions. Samples of 1 x 107 cells were lysed and 
homogenized in the presence of a highly denaturing guanidine-thiocyanate-containing 
buffer. This buffer leads to immediate inactivation of RNases, ensuring purification of 
intact RNA. Then ethanol was added to provide appropriate binding conditions and the 
sample was applied to a spin column. Total RNA were bound to column membrane and 
contaminants were efficiently washed away. RNA was then eluted in 20 - 30 μL RNase-
free water. All bind, wash, and elution steps were performed by centrifugation at 22 – 
25°C in a standard microcentrifuge set at 300 g. Genomic DNA contamination was 
eliminated using an on-column DNA digestion kit. The total RNA concentration and 
purity was determined by a spectrophotometer. Complementary DNA was synthesized 
from 2 µg of total RNA using oligo(dT)15 primer, dNTPs (10 mM), rRNAsin 
ribonuclease inhibitor, DTT (0.1 M), 5 x first-strand buffer (250 mM Tris-HCl, 375 
mM KCl, 15 mM MgCl2) and 200 U/ μL SuperScript III Reverse Transcriptase in a 20 
μL reaction volume. Annealing was performed by a thermocycler for 5 minutes at 65°C 
with rapid cooling at 4°C. Then reverse transcription was carried out for 60 minutes at 
55°C, followed by 15 minutes at 70°C, with a final cool down to 4°C. 
 
Material description Type Company 
oligo(dT)15 primer solution Promega 
ribonuclease inhibitor rRNAsin Promega 
10mM dNTPs solution Invitrogen 
reverse Transcriptase SuperScript III  Invitrogen 
RNA purification kit RNeasy mini kit Qiagen 
on-column DNA digestion kit RNase-free DNase set Qiagen 
centrifuge Heraeus Primo R  Thermo Scientific 
spectrophotometer NanoDrop ND-1000 Thermo Scientific 
thermocycler  MJ Mini  Bio-Rad Lab 
vortex mixer  Galaxy mini VWR 
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2.3.3 Quantitative real-time PCR  
Quantitative real-time PCR (qRT-PCR) was performed with a real-time PCR system 
using TaqMan Gene Expression Assays according to the instructions of the 
manufacturer. Reaction mixtures included specific primers for TLR2 and TLR4. Human 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used for normalization of 
each sample (housekeeping gene). Relative gene expression of TLRs was determined 
based on the threshold cycle (CT) values. Only CT values less than 35.5 were included. 
Results were normalized according to the formula: ∆CT = CT target gene - CT GAPDH. ∆CT 
values of samples were averaged and relative gene expression of LPS - treated cells(s) 
and calibrator(c) sample (i.e. untreated cells) were calculated following the delta/delta 
calculation method (2־ (∆∆Ct (s) - ∆∆Ct (c)). Relative gene expression of the calibrator sample 
is always one. Standart error (SE) of normalized target gene expression relative to 
GAPDH was calculated from the initial SEs of target gene and GAPDH. Each sample 
was tested in quadruplicate. Calculations were performed with spreadsheet software. 
 
Material description Type Company 
Real-Time PCR System  StepOnePlus Applied Biosystems 
TaqMan Gene Expression Assay TLR2, Hs01014511_m1  Applied Biosystems 
TaqMan Gene Expression Assay TLR4, Hs00152939_m1  Applied Biosystems 
TaqMan Gene Expression Assay GAPDH, Hs99999905_m1 Applied Biosystems 
TaqMan Universal Master Mix No AmpErase UNG Applied Biosystems 
spreadsheet software  Microsoft Excel  Microsoft Windows 
 
2.3.4 TLR expression by FACS 
To determine the expression of TLR2 and TLR4 on DFPCs and BMSCs, cells were 
treated with 50 μg/ mL P. gingivalis LPS for 24 hours and FACS analysis were 
performed as described above (Section 2.2.5). Antibodies used in the assay are shown 
in Table 2.3.4.  
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Antibody Conjugate Isotype Company  
TLR2 FITC mouse IgG2a   eBioscience 
TLR4 Alexa Fluor 488 mouse IgG2a   eBioscience 
 
Table 2.3.4 Antibodies for analytical fluorescence-activated cell sorting. 
 
2.3.5 In vitro wound healing assay 
An established in vitro wound healing model was used for the study of cell wound 
healing rates. DFPCs and BMSCs were cultured in 24-well plates until they reached 
90% confluence. Afterwards, a disposable plastic pipette tip (200 μL) was used to 
prepare a scratch across the monolayer of cells. Intact cells were gently washed twice 
with PBS to remove debris created by wounding and culture medium was added for the 
remainder of incubation. The extent of repopulation of the wound area was assessed for 
up to 24 hours by live imaging, processed by ELYRA PS.1 LSM-780. The latter is a 
confocal video-microscopy station, equipped with a motorized stage incubator for 
automated sample positioning and accurate control of air temperature and carbon 
dioxide concentrations, set at 37°C and 5% CO2, respectively. The use of a controlled 
large incubator, enclosing the entire stage and objectives, allowed the stable long-term 
video imaging of live cells. The sequential images were captured by a CCD video 
camera every 3 minutes, thus allowing the real-time observation of the in vitro healing 
process. During the assay, cells from the edges of the wounded area migrated toward 
the wound. The average wound dimensions were measured using graphic editing 
software. In order to determine the migratory activity of LPS-treated cells, rates of 
wound healing were calculated at several time points; normalized to untreated controls 
and finally expressed as percentages of cell migratory activity. 
Material description Type Company 
microscope  ELYRA PS.1 LSM-780 Carl Zeiss 
CCD video camera AxioCam MR  Carl Zeiss 
graphics editing software ZEN2011 software Carl Zeiss 
graphics editing software AxioVision Rel 4.5 SP1 Carl Zeiss 
computer Extensa 3002 WLMi   Acer 
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2.3.6 Detection of IL-6 by enzyme linked immunosorbent assay (ELISA) 
For quantitative detection of human IL-6 in cell cultures, supernatants collected from 
LPS-treated as well as untreated DFPC and BMSC cultures were analyzed by a 
commercially available sandwich ELISA kit. According to the instructions of the 
manufacturer, 96-well immunoplates were coated overnight at 4°C with 100 μL of 
coating buffer containing anti-human IL-6 capture antibody (diluted 1:100 in PBS). 
After removing the coating buffer plates were blocked with 300 μL of blocking solution 
at room temperature for 1 hour. Then blocking solution (containing PBS and 4% HSA) 
was poured off and 100 μL of culture supernatants was placed in wells at room 
temperature for 1 hour. After washing 5 times with wash solution (containing PBS and 
0.1% Tween20), 100 μL of biotinylated detector antibody (anti-human IL-6, diluted 
1:100 in reagent diluent) was placed in each well at room temperature for 1 hour. Serial 
dilutions of human recombinant IL-6 standard, whose concentrations spanned an 
effective assay range (8 - 1000 pg/ mL), were included in each well plate to obtain a 
standard curve. Wells containing culture medium only served as blank controls for 
nonspecific antibody binding. After washing, 100 μL of streptavidin diluted 1:8000 in 
reagent diluent was placed in each well for 30 minutes and incubated in the dark at 
room temperature. After washing, 100 μL of TMB substrate was added into each well, 
followed by incubation at room temperature for 20 minutes. The development of the 
colour reaction was controlled and as it was sufficiently proceeded 50 μL stop solution 
(2N hydrochloric acid) was added. Absorbance values were measured at 450 nm by a 
microplate reader. The quantity of IL-6 was calculated as the change in absorbance 
values which were proportional to the amount of protein captured in wells. For the 
standard curve, the absorbance values for different known concentrations of IL-6 
standard were plotted and a best-fit line drawn through the points. The unknown 
concentrations of samples tested at the same time could be determined by reference to 
the standard curve. To estimate the relative amount of IL-6 assayed culture supernatants 
the absorbance values of the samples were compared to the absorbance values of 
standard IL-6. 
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Material description Type Company 
ELISA kit human interleukin-6 ImmunoTools 
Multiwell cell culture plates Nunc Maxisorp, 96 wells  Thermo Scientific 
Tween20 viscous liquid Sigma-Aldrich 
Streptavidin-HRP solution, 1.25 mg/ mL Invitrogen 
TMB substrate/ stop solution solution Sigma-Aldrich 
 
2.4 Statistical analysis 
The experiments were performed in at least three independent repeats for each cell 
population. All results are presented as means ± standard error (SE). Statistical analyses 
were performed utilizing the SigmaStat 3.5 software package. Differences were 
considered statistically significant at p < 0.05. 
 
Material description Type Company 
statistical software SigmaStat 3.5 Systat Software 
computer VGN-NS21M Sony 
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3. Results 
3.1 Cell characterization 
3.1.1 Isolation and culture of DFPCs 
In the present study, human DFPCs were obtained from freshly extracted dental follicle 
tissues (n = 6). Cells were isolated by their ability to adhere to a plastic substratum. 
Non-adherent cells were discarded 2 - 3 days after isolation. Only a low number (n = 3 -
5) of attached single cells were able to grow and form primary cultures. DFPCs were 
characterized by a flattened, spindle-shaped, fibroblast-like morphology with multiple 
processes (Fig 3.1.1). DFPCs were cultivated in stem cell growth medium under 
standard culture conditions and reached 80% confluency in 3 weeks. Parallely, human 
BMSCs, isolated from bone marrow aspirates by plastic adherence, showed similar 
morphological features and were cultured under the same conditions as DFPCs. In the 
subsequent experiments DFPCs properties were analyzed and compared to BMSCs, a 
population of non-dental origin multipotent cells. 
 
  
 
Figure 3.1.1 Microscope images showing typical (A) DFPCs and (B) BMSCs morphology, 100x. 
 
3.1.2 Clonogenic and proliferative properties of DFPCs 
First passage DFPCs and BMSCs were evaluated for their ability to form colonies. 
Single-cell suspensions of both cell populations were seeded at low densities. After 12 
days in culture the total number of colonies was determined microscopically. The 
colony forming efficacy (CFE) of cells derived from dental follicle tissues was 20.4 ± 
2.8%, while the incidence of BMSCs CFE (5.3 ± 1.5%) was significantly lower ( p < 
0.05) (Fig. 3.1.2a). 
A. B. 
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Figure 3.1.2a Representative light microscope images of a DFPCs colony after (A) 1 day, (B) 4 days 
and (C) 7 days of cultivation, 100x magnification. (D) Colony forming efficiency of 
DFPCs and BMSCs; DFPCs n = 5, BMSCs n = 4, values represent means ± SE, *p < 
0.05 (Student’s t-test). 
 
Cell proliferation of both DFPCs and BMSCs was assessed by continuous 4-day MTT 
assays. Results were expressed as percentages of cell viability and corresponding 
growth curves were plotted. Statistical analysis revealed no significant differences 
between the proliferation rates of both cell populations (Fig. 3.1.2b). 
 
 
Figure 3.1.2b Cell proliferation rates of DFPCs and BMSCs assessed by MTT dye reduction assay; 
DFPCs n = 5, BMSCs n = 4, values represent means ± SE. 
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3.1.3 Immunophenotypic characterization of DFPCs 
In order to determine the phenotypic profile of DFPCs, fluorescence-activated cell 
sorting (FACS) was performed. A typical panel of stem cell markers was used to 
identify surface antigens of cultured DFPCs. According to results DFPCs exhibited a 
strongly positive expression of a variety of surface markers (CD29, CD44, CD73, 
CD90 and CD105). DFPCs failed to react with hematopoietic markers CD14 (monocyte 
and granulocyte marker) and CD45 (common leukocyte antigen). Analysis of surface 
epitopes by FACS is shown in Figure 3.1.3. The immunophenotypic analysis of BMSCs 
revealed similar results (data not shown) (Mark 2013). 
 
 
 
CD14 CD29 CD44 CD45 CD73 CD90 CD105 
0 ± 0% 99.8 ± 0.02% 99.7 ± 0.08% 0 ± 0.02% 98.7 ± 0.5% 82.4 ± 1.6% 82.9 ± 6.2% 
 
 
Figure 3.1.3 (A) Immunophenotyping of human DFPCs by flow cytometry after staining for specific 
CD surface markers. DFPCs were positive for typical stem cell markers CD29, CD44, 
CD73, CD90 and CD105. No expression of haematopoietic markers CD14 and CD45 
was detected. Bright areas indicate CD marker isotope controls. (B) Surface marker 
expression values are presented in percentages; n = 3, values represent means ± SE. 
A. 
B. 
CD14 CD29 CD44 CD45 
CD73 CD90 CD105  
Isotope control 
 
Marker expression 
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3.1.4 Differentiation potential of DFPCs  
The multipotency of DFPCs was verified by in vitro functional differentiation assays. 
DFPCs were cultured in various induction media and their ability to differentiate 
towards multiple lineages was evaluated. Adipogenic induction was apparent by the 
accumulation of lipid-rich vacuoles within the cells, when cells were placed in 
adipogenic medium for 2 weeks. Differentiation became evident after 7 - 9 days after 
induction and most adipocytes were observed near the well center. Lipid droplet 
formation in adipocytes was verified by Oil Red O staining (Fig. 3.1.4a) and 
immunostaining (Fig. 3.1.4d). When placed in osteogenic differentiation medium for 2 
weeks, cells formed mineralization nodules, as revealed by Alizarin red staining (Fig. 
3.1.4b) and immunostaining (Fig. 3.1.4e). The calcium deposits were scattered 
throughout the cell moonolayer as single mineralized clusters.Finally, culturing cells 
into chondrogenesis induction medium for 3 weeks resulted in the development of 
chondrocyte pellets. Safranin O staining (Fig. 3.1.4c) revealed a homogeneous 
distribution of sulfated proteoglycans within the cell pellets matrix and was confirmed 
by positive immunostaining (Fig. 3.1.4f). Immunostaining negative controls, applied in 
the absence of primary antibody, did not stain (data not shown). BMSCs used in the 
study were also able for multiple mesodermal lineage differentiation (Mark 2013). 
 
      
      
Figure 3.1.4 Multiple mesodermal lineage differentiation capacity of DFPCs in vitro.    
Adipogenesis was confirmed by Oil Red O staining (a) and immunostaining (d), 400x. 
Osteogenesis became evident after Alizarin Red staining (b) and immunostaining (e), 
100x. Chondrogenesis was verified by Safranin O staining (c) and immunostaining (f), 
10x; n = 3. 
a. 
f. e. d. 
c. b. 
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3.2 LPS treatment 
3.2.1 LPS cytotoxic effects on DFPCs 
To verify whether LPS evokes cytotoxicity effects on DFPCs and BMSCs, cell viability 
was examined by MTT assays. Interestingly, cell viability of both populations was not 
affected, even when cells were treated with a high LPS dosage (50 μg/ mL) or for a 
long period (72 hours) (Fig. 3.2.1). 
 
 
Figure 3.2.1 Cell viability rates of DFPCs and BMSCs assessed by MTT dye reduction assay; 
DFPCs n = 7, BMSCs n = 6. 
 
3.2.2 TLR2 and TLR4 expression in DFPCs 
The expression of TLR2 and TLR4 in both DFPCs and BMSCs was comparatively 
analyzed. The gene and protein expression levels of TLRs were determined by qRT-
PCR and flow cytometry, respectively. 
According to the results, both cell populations expressed low levels of TLR2 and TLR4 
mRNA. Notably, the mRNA levels of TLR4 expression were significantly higher when 
compared to TLR2 gene expression (p < 0.05). The expression of TLR4 was higher in 
BMSCs compared to DFPCs (p < 0.05). Further, TLR2 and TLR4 gene expression was 
tested in cells stimulated for 24 hours with 50 μg/ mL P. gingivalis LPS. This high dose 
LPS treatment did not influence the expression level of TLR2 mRNA, whereas gene 
expression of TLR4 was significantly downregulated (p < 0.05, Fig. 3.2.2a). 
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Figure 3.2.2a (A) Relative gene expression of TLR2 and TLR4 analysed by qRT-PCR. Histogram 
scale is inverted, so that higher bars represent higher levels of mRNA; DFPCs n = 4, 
BMSCs n = 3, values represent means ± SE, *p < 0.05 (Student’s t-test). (B) Gene 
expression fold change of TLR2 and TLR4 after LPS treatment. Data were analyzed by 
the delta/delta calculation method; DFPCs n = 4, BMSCs n = 3, values represent means 
± SE, *p < 0.05, **p < 0.01 (Student’s t-test). 
 
The expression of TLR2 and TLR4 was confirmed also at protein level for both DFPCs 
and BMSCs. According to FACS analysis, both cell populations expressed low levels of 
TLR2 and TLR4 (Fig. 3.2.2b). Protein levels of TLR4 were significantly higher than 
TLR2 on DFPCs (p < 0.001). The expression of TLR4, but not TLR2, was upregulated 
on LPS-treated BMSCs (p < 0.05). Finally, TLR2 and TLR4 protein expression on 
DFPCs was not significantly affected by LPS treatment. 
 
Figure 3.2.2b (A) Protein expression of TLR2 and TLR4 in DFPCs and BMSCs was evaluated by 
flow cytometry. Representative FACS histograms of TLR2 and TLR4 expression are 
shown. (B) TLR2 and TLR4 were expressed at low levels on both DFPCs and BMSCs. 
The expression of TLR2 was significantly lower than TLR4. The TLRs expression 
level of DFPCs was not significantly influenced by LPS treatment, while the expression 
of TLR4 on LPS-treated BMSCs was elevated; DFPCs n = 5, BMSCs n = 4, values 
represent the means ± SE, *p < 0.05, **p = 0.01, ***p < 0.001 (Student’s t-test). 
A. B. 
A. B. TLR2 DFPCs TLR4 DFPCs 
TLR4 BMSCs TLR2 BMSCs 
Isotype control        Marker expression       LPS treatment 
 
Δ
C
t 
V
a
lu
e 
10 
15 
20 
1 
0 
TLR2                 TLR4 TLR2                 TLR4 
G
en
e 
ex
p
re
ss
io
n
 
fo
ld
 c
h
a
n
g
e
 
BMSCs 
DFPCs   
BMSCs 
DFPCs   
S
u
rf
a
ce
 m
a
rk
er
 
ex
p
re
ss
io
n
, 
%
 
TLR2     TLR2     TLR4    TLR4                 
LPS                       LPS               
BMSCs 
DFPCs   
6 
3 
0 
* 
** 
* 
* 
* 
*** * 
** 
Results    45 
 
3.2.3 Migration potential of DFPCs 
To test whether LPS can affect cell migration, DFPC as well as BMSC cultures were 
subjected to in vitro scratch assays. This assay allows the observing of the healing 
process in vitro. Data analysis indicated that cells migrated in a linear fashion. As 
shown in Figure 3.2.3, LPS-treated DFPCs had a 43.5% higher migratory capacity 
compared to untreated controls (p < 0.05), suggesting that LPS may promote DFPCs 
basal motility. Interestingly, LPS treatment had no significant impact (p > 0.05) on 
BMSCs migration rates. 
 
 
 
Figure 3.2.3 (A) Representative images of in vitro wound healing scratch assay. After scratching a 
confluent cell monolayer of cells, surrounding cells migrated into the scratched area 
(time after scratching is indicated). White lines represent wound edges at t = 0 hour. 
Dotted red lines represent wound dimensions during cell migration at three different 
time points, 10x. (B) Migratory activity rates after LPS treatment. Average wound 
dimensions were measured at several time points; data were normalized to untreated 
controls and results were expressed as percentages of migratory activity; DFPCs n = 4, 
BMSCs n = 3, values represent means ± SE, *p < 0.05 (Student’s t-test). 
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3.2.4 IL-6 secretion by DFPCs 
Next, LPS induced IL-6 secretion was analyzed by examining culture supernatants of 
both cell types. No IL-6 could be measured in the supernatants of DFPCs. In all tested 
samples the detected signal was never higher than that of medium control. On the 
contrary, BMSCs produced IL-6 (Fig. 3.2.4). Cytokine secretion by BMSCs was 
upregulated after 24 hours of LPS treatment in a dose-independent manner (p > 0.05). 
Treatments for 72 hours also led to elevated IL-6 secretion, which was also independent 
from the LPS dosage used (p > 0.05). These results suggest that BMSCs produced daily 
approx. 300 pg/ mL of IL-6. Interestingly, cytokine secretion seemed to reach a plateau 
of approx. 1600 pg/ mL, even by high LPS concentration. It is also important to 
mention that the elevated cytokine production by BMSCs was not due impaired cell 
viability, as this was not affected by any LPS treatment. 
 
 
 
Figure 3.2.4 Histograms show IL-6 secretion by DFPCs and BMSCs, measured after 24 hours (A) 
and 72 hours (B) of LPS stimulation by ELISA. Limit of detection was 8 pg/ mL. Each 
sample was tested in triplicate; DFPCs n = 3, BMSCs n = 5, values represent means ± 
SE, p > 0.05 (Student’s t-test). 
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4. Discussion 
Dental follicle progenitor cells represent a population of multipotent cells derived from 
the loose ectomesenchyme-derived connective tissue surrounding the developing tooth 
germ prior to eruption (Ten Cate 1997). Here, human DFPCs were isolated from freshly 
extracted dental follicle tissues of wisdom teeth by applying previously developed 
methodology (Morsczeck 2005). 
 
4.1 Cell characterization 
Human DFPCs, as BMSCs, represent a heterogeneous population of cells with the 
capacity to adhere to plastic surfaces and form clonogenic, fibroblastic-like colonies 
(Morsczeck 2005; Honda 2010).  
The high colony forming efficiency and proliferation of DFPCs has already been 
reported in studies comparing DFPCs to other dental-derived stem cells (Jo 2007; 
Tomic 2011; Schilardi 2012). These characteristics are attributed to the high telomerase 
activity in DFPCs (Guo 2013). Here, in comparison to BMSCs, DFPCs showed a higher 
colony-forming efficiency, but same proliferation rates. The origin of DFPCs could be 
an explanation for their superior clonogenic potential (Gronthos 2000; Jo 2007; 
Schilardi 2012), as DFPCs are obtained from developing tissues (dental follicle). On the 
contrary, source of BMSCs are matured tissues (bone marrow aspirates) at a later 
developmental state with a lower incidence of clonogenic cells (Gronthos 2003). 
Proliferation potential of DFPCs might be affected by the in vitro culture conditions, 
which also results in changes of cell/ culture morphology (De Sá Silva 2012). Thus, the 
fact, that the CFE rates of both cell populations may be influenced by the differential 
isolation protocols, should be taken into account. 
The present study demonstrated the multilineage differentiation capacity of DFPCs in 
vitro. Interestingly, although osteogenic differentiation capacity of DFPCs is well 
documented in vitro (Morsczeck 2005; Honda 2010), the ability of DFPCs to 
differentiate along the adipogenic and chondrogenic pathway have been controversially 
discussed. These conflicting results have been attributed to the inherent variability of 
DFPCs populations (Lindroos 2008; Haddouti 2009; Honda 2011; Mori 2012). It is 
suggested that the heterogeneity of DFPCs could in fact be reflective of the cell 
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maturity stage along the adipogenic and chondrogenic differentiation pathways (Luan 
2006; Guo 2013). Here, DFPCs were demonstrated to have the ability to differentiate 
towards the osteogenic, adipogenic and chondrogenic lineage, when cultured with 
special induction media, as already reported in the literature (Kemoun 2007; Jo 2007; 
Yagyuu 2010; Tomic 2011). 
Further, both DFPCs and BMSCs were analyzed for expression of typical stem cell 
markers by flow cytometry. In accordance with reports from the literature (Nauta 2007; 
Huang 2009; Gaebel 2011), DFPCs and BMSCs were identified as CD29, CD44, CD73 
and CD105 positive cells. Both cell populations expressed these cell markers with 
similar high intensity while no expression of CD14 (monocyte and granulocyte marker) 
and CD45 (common leukocyte antigen) was observed. Thus, together with the 
multilineage differentiation potential of DFPCs, the minimal criteria for defining 
DFPCs as multipotent mesenchymal stem cells were fulfilled (Dominici 2006). 
 
4.2 Effects of P.gingivalis LPS on DFPCs in vitro 
4.2.1 Effects on cell viability 
In this study several concentrations of P.gingivalis LPS (0, 1, 10 and 50 μg/ mL) and 
three time points (0, 24 and 72 hours) were used in order to determine the effects on cell 
viability of both DFPCs and BMSCs. It is already demonstrated that the concentrations 
and compositions of subgingival microflora vary greatly depending on the local micro-
environmental conditions (Socransky 2005). Thus, P.gingivalis LPS concentration used 
here was thought to be superoptimal to resemble the high LPS concentrations likely to 
be found in the subgingival plaque of periodontal pockets. Besides, this experimental 
model may allow us to support the clinical meaning of our in vitro study. 
Interestingly, P.gingivalis LPS had no statistically significant influence on both cell 
populations - independent from LPS dose used and treatment duration. These results are 
in agreement with previous literature reports demonstrating the low cytotoxic activity of 
P.gingivalis LPS (Kadono 1999; Mo 2008; Wang 2010; Zhang 2010; Sipert 2013). This 
fact could be explained by the low endotoxic potencies of P.gingivalis LPS in 
comparison to lipopolysaccharide derived from enteric bacteria, like Escherichia coli 
(Horiba 1989; Dixon 2005; Muthukuru 2005; Belibasakis 2007; Kocgozlu 2009; Jain 
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2010; Jotwani 2010). Specifically, P.gingivalis LPS is characterized by the unique 
structure of lipid A (Millar 1986; Ogawa 2007), which is also supposed to be 
responsible for the weak immunogenic properties of P.gingivalis (Darveau 1998; Liu 
2008a). 
 
4.2.2 Effects on TLR2 and TLR4 expression 
In order to unveil DFPCs responsiveness to LPS, analyses of TLR2 and TLR4 
expression were performed. According to our results, DFPCs express both TLR2 and 
TLR4 in mRNA and protein levels. Tomic et al. also demonstrated the expression of 
TLR3 and TLR4 on human DFPCs (Tomic 2011). Parallely, the expression of TLR2 
and TLR4 was confirmed in BMSCs. These results are in accordance to recent studies 
showing the expression of TLRs in MSCs (Liotta 2008; DelaRosa 2010). Further, 
Pevsner-Fischer et al. confirmed the expression of functional TLRs by analyzing the 
responses of MSCs to TLR agonists (Pevsner-Fischer 2007).  
Here, the impact of LPS treatment on the expression of mRNA encoding for TLR2 and 
TLR4 was comparatively evaluated in DFPCs and BMSCs. The significant down-
regulation of TLR4 mRNA in both cell populations might be part of an adaptive 
mechanism of cells being exposed to bacteria, as already proposed (Mo 2008). On 
protein level the expression of TLR4 was significantly elevated only on LPS-treated 
BMSCs, while the expression levels of TLR4 in DFPCs remained unchanged. Activated 
TLRs are supposed to deliver signals produced by injured tissues, thus contributing to 
host immune response and tissue repair processes (Wang 2002). Hwa Cho et al. already 
proposed the idea that activation of hMSCs through TLR ligands may alter their TLR 
expression pattern and stem cell fate (Hwa Cho 2006). The fact that LPS treatment did 
not influence significantly the expression of TLRs by DFPCs might signal the tolerant 
character of this cell population in the presence of toxins. Nevertheless, the underlying 
mechanism for this tolerizing phenomenon is not yet known. 
Notably, LPS did not influence the TLR2 gene expression in both cell populations, 
whereas the expression of TLR4 was significantly altered. These results support the 
idea that LPS could be recognized through TLR4 (Darveau 2004), as TLR2 is supposed 
to be mainly responsible for lipoprotein and lipopeptide sensing (Jin 2008). On the 
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contrary, Bainbridge et al. reported that P.gingivalis LPS may activate both TLR2 and 
TLR4 in human embryonic kidney cells (Bainbridge 2002). However, the same study 
demonstrated the heterogeneity of P.gingivalis LPS used in the experiments. These 
controversial data might be explained by the differential experimental approaches and 
emphasize the complexicity of signaling cascades that activate TLRs. 
 
4.2.3 Effects on cell migration potential 
The innate regenerative potential of the periodontium has been extensively investigated 
and clearly appears to be dependent on wound management (Ivanovski 2006). Current 
research focuses on identifying biologic factors that favor migration and proliferation of 
stem cells, thus promoting healing and regeneration of the periodontium (Fuseler 2012; 
Felthaus 2013). A profound understanding of biological and clinical variables could be 
critical for the effective optimization and increased predictability of periodontal-
regenerative therapies (Polimeni 2006). 
In fact, migration to the appropriate site of injury is considered to be critical for the 
therapeutic efficacy of stem cells (DelaRosa 2010; Vertelov 2013). It is proposed that 
migratory activity of stem cells is strongly dependent on their local or systemic 
inflammatory context (Ponte 2007). Several studies have already described an 
enhancement of MSCs mobility after stimulation with TLR agonists. Waterman et al. 
suggest that MSC polarization could be an explanation to the effect of TLR stimulation 
and its downstream consequences on the migratory properties of stem cells (Waterman 
2010). Another study on human BMSCs supports the notion that the stimulation of 
BMSCs with TLR agonists led to the activation of downstream signaling pathways, 
including NF-κB, Akt and MAPK (Tomchuck 2008). Park et al, also, demonstrated that 
LPS may promote the migration ability of murine odontoblast-like cells via TLR4 
through the ERK and PI3/Akt signaling pathways (Park 2011). 
In this context, we sought to analyze the effects of TLR stimulation on the migration 
rates of DFPCs by an in vitro wound healing model. Interestingly, LPS treatment 
enhanced significantly the wound healing efficiency of DFPCs compared to the 
untreated controls. These data suggest a positive impact of LPS on the mobility of 
DFPCs, which could play a pivotal role in tissue repair processes. On the contrary, LPS 
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treatment had no significant impact on the migration rates of BMSCs in this study. The 
differential migration rates of DFPCs and BMSCs could be explained by the proposed 
theory that responses to TLR ligands are cell-type specific (Lundberg 2007). The fact 
that DFPCs originate from developing tissues (dental follicle) may also provide an 
explanation for their enhanced migratory potential upon stimulation (Gronthos 2000). 
 
4.2.4 Effects on IL-6 secretion 
There are numerous signalling molecules involved in cell migration. Signaling 
pathways that control migration of MSCs, involve chemoattractant-receptor axes and 
intracellular signalling pathways. Moreover, extracellular matrix and biophysical 
factors play important role in guiding migration of MSCs (Li 2011). IL-6 is a 
multifunctional cytokine, involved in the initiation of host inflammatory processes 
against periodontal pathogens, leading to periodontal bone loss (Graves 2008). Indeed, 
high levels of IL-6 have been associated with the presence of chronic periodontitis in 
patients (Nibali 2011). Besides, the direct induction of IL-6 secretion after cell 
stimulation with P.gingivalis LPS is well documented (Steffen 2000; Imatani 2001; 
Feldman 2011; Herath 2011; Zhao 2012).  
Here we focused on the possible role of IL-6 in the migration of LPS-treated DFPCs. 
Recent reports support the notion that secreted IL-6 may act in a paracrine fashion on 
MSCs, thus enhancing migratory potential and cell survival (Schmidt 2006; Rattigan 
2010; Tsai 2012). Remarkably, the analysis of IL-6 secretion showed no cytokine 
sekretion by DFPCs, as previously reported (Morsczeck 2012). These results could 
imply that DFPCs do not participate in the initiation of inflammatory processes and 
retain a tolerant character under the influence of toxins. Further, it could be assumed 
that IL-6 was not responsible for the enhanced migratory activity of LPS-treated 
DFPCs. The exact mechanisms leading DFPCs migration remain to be elucidated. On 
the contrary, the secretion of IL-6 by BMSCs was elevated after LPS treatment. 
Raicevic et al. already demonstrated that MSCs responsiveness to TLR ligands may 
cause alterations of their cytokine secretion profile (Raicevic 2010). These data may 
support the idea that TLR signalling is involved in the production of IL-6 by MSCs, as 
part of their pro-inflammatory shift, at sites of inflammation (Frost 2005; Pevsner-
Fischer 2007; DelaRosa 2010; Waterman 2010). 
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5. Conclusions 
In conclusion, analysis of data presented here indicates that DFPCs represent a 
population of multipotent cells with unique properties. According to the results, DFPCs 
shared common properties with BMSCs, but also significant differences in their 
biological responses. Thus, DFPCs were highly clonogenic and proliferative, while 
expressing same stem cell surface markers, as BMSCs. Furthermore, it was 
demonstrated that both DFPCs and BMSCs were positive for TLR2 and TLR4 
expression. Notably, LPS treatment provoked differential responses in both cell 
populations. In case of TLRs, their expression in DFPCs seemed to remain unchanged 
after LPS treatment. On the contrary, TLR4 expression in BMSCs was significantly 
upregulated. Further, LPS treatment resulted in elevation of DFPCs migration rates. 
Nevertheless, DFPCs did not produce IL-6 even under the influence of LPS. These 
results let us speculate that the enhanced migratory ability of DFPCs was not IL-6 
driven. On the contrary, BMSCs were responsive to LPS by showing higher levels of 
IL-6 production. Moreover, the in vitro wound healing ability of BMSCs was not 
affected either by LPS stimulation or by the elevated levels of IL-6.  
According to the above results, we suggest that DFPCs are able to response to bacterial 
LPS. However, DFPCs seem to retain a tolerant character under the influence of toxins. 
We speculate that DFPCs may not actively participate in the initiation of immune 
response of the host. The enhanced cell viability and wound healing rates of LPS-
treated DFPCs may indicate the applicability of this cell population in cell-based 
regenerative approaches. A better understanding of DFPCs behavior in sites of infection 
is needed to support this tempting conception. 
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6. Summary 
 
Periodontitis represents one of the major oral health burdens worldwide. It is a 
bacterially induced inflammatory disease, characterized by the destruction of tooth-
supporting tissues. Particularly, certain bacteria strains, such as Porphyromonas 
gingivalis, are believed to be greatly involved in the initiation and progression of the 
disease. Thus, conventional periodontal treatments are based on root surface 
debridement and disinfection of diseased periodontal tissues. Nevertheless, these 
therapeutic approaches have proved to be insufficient to attain complete and predictable 
regeneration of the periodontium. 
Currently, much progress has been made in understanding the cellular and molecular 
events involved in formation of the periodontium. The presence of multipotent cells in 
dental tissues has been demonstrated. These cell populations are proposed as suitable 
candidates for cell-based periodontal therapies. Specifically, dental follicle is 
considered as source of multipotent cells. Experimental studies have shown that dental 
follicle progenitor cells (DFPCs) may support repair and regeneration of the 
periodontium in vivo. Thus, DFPCs have been proposed as biological grafts for cell-
based therapies. Nevertheless, it is speculated that delivery of DFPCs in bacterially 
colonized periodontal pockets may cause alterations in their functional and phenotypic 
profile. 
Aim of this study was to investigate the ability of DFPCs to sense and respond to 
P.gingivalis lipopolysaccharide (LPS). The influence of LPS on DFPCs was evaluated 
in terms of cell viability, TLR2 and TLR4 expression, migratory capacity and IL-6 
secretion. Additionally, DFPCs properties were compared to bone marrow stem cells 
(BMSCs), a well-studied class of adult stem cells.  
Human DFPCs were isolated from dental follicle tissues of freshly extracted wisdom 
teeth. After testing their multipotent characteristics, DFPCs were treated with different 
doses of P.gingivalis LPS at several time periods. Toll-like receptors (TLR) 2 and 4 are 
believed to be essential for the recognition of P.gingivalis LPS. The analysis by qRT-
PCR and flow cytometry indicated that DFPCs, similar to BMSCs, expressed low levels 
of both TLR2 and TLR4 at gene and protein level, respectively. Concretely, the 
expression of TLRs in DFPCs remained unchanged after LPS treatment, while TLR4 
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expression in LPS-treated BMSCs was significantly upregulated. According to in vitro 
scratch assays, LPS treatment resulted in elevation of DFPCs migration rates that is 
essential for wound healing processes. Furthermore, assays on the secretion of 
interleukin-6 (IL-6), a pro-inflammatory cytokine and potent stimulator of cell 
migration, have been undertaken. Interestingly, the levels of IL-6 secretion of DFPCs 
and BMSCs remained unchanged after LPS treatment. Finally, conduction of MTT 
assays demonstrated no influence of LPS on viability rates of both cell populations. 
Taken together, these results suggest that DFPCs were able to sense and respond to P. 
gingivalis LPS. However, DFPCs seemed to retain a tolerant, non-inflammatory 
character under the influence of toxins. On the other hand, the enhanced wound healing 
rates of LPS-treated DFPCs may indicate the applicability of this cell population as 
biological graft in cell-based regenerative approaches. Further in vivo studies are 
needed to support this tempting conception. Conclusively, this study provides new 
insights into understanding the physiological role of dental-derived progenitor cells in 
sites of periodontal infection. 
Thesis statements    55 
 
7. Thesis statements 
 
1. Dental follicle progenitor cells (DFPCs) are able to sense and respond to 
Porphyromonas gingivalis lipopolysaccharide (LPS). 
2. DFPCs responses to P. gingivalis LPS are differential in comparison to bone 
marrow stem cells (BMSCs). 
3. DFPCs, similar to BMSCs, express low levels of both Toll-like receptors (TLR) 
2 and TLR4, which are believed to be essential for the recognition of 
P.gingivalis LPS. 
4. LPS treatment has no impact on TLR2 and TLR4 expression by DFPCs, while 
TLR4 expression in LPS-treated BMSCs is significantly upregulated. 
5. According to in vitro wound healing assays, LPS treatment results in elevation 
of DFPCs migration rates. 
6. LPS treatment has no impact on DFPCs secretion levels of interleukin-6 (IL-6), 
a pro-inflammatory cytokine and potent stimulator of cell migration. 
7. DFPCs have the potential to promote periodontal wound healing under the 
influence of toxins. 
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